<!DOCTYPE html>

<html> 

<head> <!-- /main page header -->
  <meta charset="UTF-8">
   <meta name="format-detection" >
   <meta name="viewport" content="user-scalable=no, initial-scale=5, minimum-scale=1, maximum-scale=5">
   <title>BD-MIMS</title>
   <link rel="stylesheet" href="css/main.css">
   <link rel="stylesheet" href="css/themes/default/jquery.mobile-1.3.1.min.css">
   <script src="js/jquery.js"></script>
   <script src="js/jqm.js"></script>
   <script scr="js/cordova.js"type="text/javascript"></script>
   <script>
    function init() {
      document.addEventListener("deviceready", onDeviceReady, false);
    }

    function onDeviceReady() {
      alert('');
    }
  </script>
   
</head> <!-- /main page header -->


<body onload="init()"> 



 <!-- /................page............................ -->



<div data-role="page" id="" data-theme="a"> <!-- /first page -->


    <div data-role="header"> <!-- /this is header -->
      <h1>Respiratory System Drugs</h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>

    </div> <!-- /this is header -->


<div data-role="content" data-theme="a">  <!-- /content div -->
  <ul data-role="listview" data-inset="true" data-theme="b">        
                   
    <li> Bronchodilators
        <ul>
	       <li><a href="#Adrenoceptor stimulants">
	        Adrenoceptor stimulants</a>
	       </li>
	       <li><a href="#Other adrenoceptor stimulants">
	        Other adrenoceptor stimulants</a>
	       </li>
	       <li><a href="#Antimuscarinic bronchodilators">
	        Antimuscarinic bronchodilators </a>
	       </li>
	       <li><a href="#Theophylline & related drugs">
	        Theophylline & related drugs</a>
	       </li>
          <li><a href="#Compound bronchodilator prepns">
          Compound bronchodilator prepns</a>
         </li>	            
	    </ul>             
    </li>  
            

   <li>  Prophylactics of Asthma
      <ul> 
           <li><a href="#Cromoglycate & Related drugs">
            Cromoglycate & Related drugs</a>
          </li> 
          <li><a href="#Leukotriene receptor antagonists">
            Leukotriene receptor antagonists</a>
          </li>                                                                           
      </ul>    
   </li>


  
  <li><a href="#centrally acting antihypertensive drugs">
    Respiratory Glucocorticoids: Corticosteroids</a>
          </li> 
          


	<li>  Cough Preparations
	      <ul> 
	           <li><a href="#Cough suppressants">
	            Cough suppressants</a>
	          </li> 
	          <li><a href="#Combined cough suppressants">
	            Combined cough suppressants</a>
	          </li> 
	          <li><a href="#Cough expectorants & mucolytics">
	            Cough expectorants & mucolytics</a>
	          </li> 
            <li><a href="#Combined cough expectorants">
              Combined cough expectorants</a>
            </li>                                                                  
	      </ul>    
	 </li>

  <li> <a href="#Respiratory stimulants"> 
    Respiratory stimulants
	</li>

  




 </ul> 
</div> <!-- content div -->

   <div data-role="footer"data-position="fixed"> <!-- /first footer -->
      <h4></h4>
   </div><!-- /first footer -->
  </div> <!-- /first page -->
 
  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Adrenoceptor stimulants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

     

       
 <ul data-role="listview" data-inset="true" data-theme="b">

	 <li>  Short-acting selective beta2-adrenoceptor stimulants
	      <ul> 
	           <li><a href="#Salbutamol ">
	            Salbutamol </a>
	          </li> 
	          <li><a href="#Levosalbutamol">
	            Levosalbutamol</a>
	          </li> 
	          <li><a href="#Terbutaline">
	            Terbutaline</a>
	          </li>
	          <li><a href="#Bambuterol">
	            Bambuterol</a>
	          </li>
	          <li><a href="#Tulobuterol">
	           Tulobuterol</a>
	          </li>
	      </ul>    
	 </li>
	 
	 
	 <li><a href="#Long-acting selective">
	       Long-acting selective beta2 <br> adrenoceptor stimulants</a>
	          </li> 
	         
	 
</ul>  


              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Salbutamol" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Salbutamol   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> SALBUTAMOL: Tablet/Syrup/Injection <br>
          SALBUTAMOL: Inhaler (DPI/MDI) <br>
          SALBUTAMOL HFA: Inhaler (MDI)  </h3>
          <p> Salbutamol is a short-acting, selective b2- adrenoceptor stimulant (agonist), used in the treatment of asthma and other forms of diffuse reversible airways obstructive diseases. It is available as tablet, syrup, injection & inhaler/HFA inhaler.
Tablet - 2mg & 4mg tablet. <br><br>
Syrup - 2mg/5ml; 60ml & 100ml bottle.
Injection - 50mcg/ml; 20ml vial.
Inhaler (DPI) - Dry powder inhaler (DPI). Inhaler (MDI) - Metered dose inhaler (MDI),
using CFC (chlorofluorocarbon) propellant. Inhaler HFA (MDI) - Metered dose inhaler (MDI), using HFA (hydrofluoroalkane) propellant.
CFC (Chlorofluorocarbon): CFC- using as MDI propellant is safe for human, but, as it emits CFC to the environment, it harms the planet by depleting ozone layer.
HFA (Hydrofluoroalkane): Recently an advanced HFA (Hydrofluoroalkane) technology has developed as MDI propellant replacing CFC propellant. HFA is an ozone-benign, environment friendly, CFC-free MDI propellant. <br><br>

<strong>Mode of action:</strong> The primary pharmacological action of b-adrenoceptor stimulant drug is to stimulate adenyl cyclase, the enzyme which catalyzes the formation of cyclic AMP (cyclic 3, 4 adenosine-mono-phosphate) from adenosine-tri- phosphate (ATP). The cyclic AMP thus formed mediates the cellular response that results in bronchodilation.
Ind: Salbutamol is indicated for the treatment and prophylaxis of bronchial asthma and for the treatment of reversible airways obstruction associated with bronchitis and emphysema; status asthmaticus; prophylactic therapy before exertion or to prevent exercise-induced asthma. <br><br>

<strong>C/I:</strong> Although intravenous salbutamol, and occasionally oral preparations are used in the management of premature labour (not complicated by any conditions such as placenta praevia, ante- partum haemorrhage or toxaemia of pregnancy), salbutamol inhaler preparations are not appropriate for managing premature labour. Salbutamol preparation should not be used for threatened abortion during the first or second trimester of pregnancy. Salbuatmol is contraindicated in patients with a history of hypersensitivity to any of its components. <br><br>

<strong>S/E:</strong> Salbutamol is generally well tolerated and serious toxic effects are a few. 
Salbutamol may cause fine tremor of skeletal muscles (particularly of the hands), palpitations,
and muscle cramps. Tachycardia, tenseness, headache, peripheral vasodilatation & hypokalaemia have been reported after large dose. They usually disappear with continued treatment. Hypersensitive reactions including angioedema, urticaria, reflex bronchospasm, hypotension and collapse have been reported very rarely. In case of inhalation therapy, the potential for paradoxical bronchospasm should be kept in mind, if it occurs, therapy should be discontinued immediately and alternative medication should be instituted. <br><br>

<strong>Precautions:</strong> Salbutamol and other b2 agonists should be given with caution in hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to QT-interval prolongation, hypertension, and diabetes mellitus. In severe asthma, particular cautionis also required to avoid inducing hypokalaemia as this effect may be potentiated by hypoxia or by concomitant administration of other anti-asthmatic drugs; b2 agonists such as salbutamol are not appropriate for use alone in the treatment of severe asthma. Salbutamol and non-selective b-blockers such as propranolol should not be prescribed together. In the event of a previously effective dose of salbutamol inhaler, failing to give relief for at least 3 hours, the patients should be advised to seek medical advice in order that any necessary additional steps may be taken.
Inhaled salbutamol preparations are not appropriate for managing premature labor and also should not be used for threatened abortion during the first or second trimester of pregnancy.  <br><br>

<strong>Pregnancy & lactation:</strong> Although there is no evidence that salbutamol is teratogenic, it should be used in the first trimester only if absolutely essential. Inhalation has particular advantage as a mean of administration of b2 agonists during pregnancy as the therapeutic action can be achieved without the requirement for such plasma concentration liable to have a pharmacological effect on the fetus.
Salbutamol probably enters breast milk, but the concentration is unknown. However, no adverse effect have been reported in the breast-fed babies of mothers taking the drug by inhalation. <br><br>

<strong>Dosage & admin:</strong> By mouth: Adult- 2 to 4mg 3 or 4 times daily. Child- under 2 yrs. not recommended; 2-6 yrs. 1-2mg. 6-12 yrs. 2mg. Both 3 or 4 times daily. Or, 0.1 mg/kg/dose, 3 or 4 times daily.
By injection: 500mcg i.m or s.c injection, may be repeated every 4 hours if necessary. Or,
By slow i.v injection: 250mcg, repeated if necessary. <br>
By i.v infusion: Initially 5mcg/min, adjusted according to response & heart-rate usually in range 3-20mcg/min, or more if necessary.  <br>
<strong>Child:</strong> Not recommended. <br>
By metered dose aerosol inhalation (MDI): <br>
<strong>Adults:</strong> For the relief of acute bronchospasm and for managing intermittent episodes of asthma, 1 or 2 puffs (100 or 200mcg) as a single dose; for chronic maintenance therapy, 2 puffs 3 or 4 times daily; for prevention of exercise- induced bronchospasm, 2 puffs before exertion.
Prophylaxis, 2 puffs 3 or 4 times daily. Children: For relief of acute bronchospasm,
management of episodic asthma and for prevention of exercise induced bronchospasm, 1 puff; for routine maintenance and prophylaxis, 1 puff 3 or 4 times daily, increasing if necessary to 2 puffs 3 or 4 times daily.
Elderly- the dosage is the same as that for adults.
By dry powder inhalation (DPI): Adult: 200- 400mcg for persistent symptoms up to 3-4 times daily; Child 200mcg.
Prophylaxis in exercise-induced bronchospasm 400mcg; Child, 200mcg.
DPI or Dry powder inhalation is for oral inhalation only. An inhalation device (such as, Cozyhaler, Cyclohaler, Rotahaler) is used for dry powder inhalation.
Rinsing the mouth after dry powder inhalation is advised.
By inhalation of nebulised solution: Chronic bronchospasm unresponsive to conventional therapy and severe acute asthma, adult and child over 18 months 2.5mg, repeated up to 4 times daily; may be increased to 5mg if necessary, but medical assessment should be considered since alternative therapy may be indicated; child under 18 months, clinical efficacy uncertain (transient hypoxaemia may occur- consider supplemental oxygen).   </p>
        </div><!-- collapsible -->




<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTOLIN Tab. Globe</h3>
    <p>Salbutamol 4mg/tablet. 100's pack: 34.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTOLIN Syp. Globe</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ALVOLEX Syp. Silva</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100m1 bot: 16.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASMATOL Syp. Rephco</h3>
    <p>Salbutamol 2mg/5ml: syrup. 60m1 bot: 10.75 MRP
100ml bot: 16.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASMOLEX Syp. Aristopharma</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100m1 bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASTHMANIL Tab. Pharmaco Inter.</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 33.38 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASTHMOLIN Tab. Pharmadesh</h3>
    <p>Salbutamol 2mg/tablet.
2mg x 100's pack: 28.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASTHMOLIN Syp. Pharmadesh</h3>
    <p>Salbutamol 2mg/5ml: syrup 60ml bot: 11.00 MRP 100ml bot: 15.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASUL Tab. Asiatic</h3>
    <p>Salbutamol 4mg/tablet. 100's pack: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASUL Syp. Asiatic</h3>
    <p>Salbutamol 2mg/5ml: syrup.
 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AZMASOL Inhaler (MDI) Beximco</h3>
    <p>Salbutamol 100mcg/puff or actuation: metered dose inhalation (MDI).
Dosage & admin: See above under the text. 200 doses unit: 130.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AZMASOL Inhaler (Refill Can) Beximco</h3>
    <p>Salbutamol 100mcg/puff or actuation; each canister contains 200 metered doses: inhalation aerosol. (MDI)
Dosage & admin: See above under the text. 200 doses canister: 100.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AZMASOL HFA Inhaler (MDI) Beximco</h3>
    <p>Salbutamol 100mcg/puff or actuation: metered dose inhaler (MDI), using HFA (hydrofluoroalkane) as propellant.
Dosage & admin: See above under the text. 200 doses unit: 160.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AZMASOL HFA Inhaler (Refill Can) Beximco</h3>
    <p>Salbutamol 100mcg/puff or actuation; each canister contains 200 metered doses: inhalation aerosol. (MDI), using HFA (hydrofluoroalkane) as propellant.
Dosage & admin: See above under the text. 200 doses canister: 130.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AZMET Syp. Medicon</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100ml bot: 13.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROAD Syp. Nipa</h3>
    <p>Salbutamol 2mg/5ml: syrup 100m1 bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRODIL Tab. ACI</h3>
    <p>Salbutamol 2mg & 4mg/tablet.
2mg x 500's pack: 130.00 MRP
4mg x 500's pack: 170.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRODIL Syp. ACI</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100ml bot: 16.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLAX-2 Tab. Somatec</h3>
    <p>Salbutamol 2mg/tablet 100's pack: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLAX-4 Tab. Somatec</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 33.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLAX Syp. Somatec</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONCOTROL 4 Tab. Pacific</h3>
    <p>Salbutamol 4mg/tablet 200's pack: 68.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONCOTROL Syp. Pacific</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100m1 bot: 16.11 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONDYL Syp. Millat</h3>
    <p>Salbutamol 2mg/5ml: syrup. 100m1 bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONKOLAX-2 Tab. Beximco</h3>
    <p>Salbutamol 2mg/tablet 100's pack: 26.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONKOLAX-4 Tab. Beximco</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 34.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRONKOLAX Syp. Beximco</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 16.08 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CYBUTOL Cap. 200 Inhaler (DPI)</h3>
    <p>Pharmachemie/City Overseas
Salbutamol 200mcg/capsule; dry powder</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CYBUTOL Cap. 400 Inhaler (DPI)</h3>
    <p>Cybutol capsule inhaler (DPI) is administered by 'cyclohaler' device through oral inhalation route. inhalation route. Dose: See above under the text.100 caps pack: 350.00 TP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>D-BUTAMOL Tab. Doctor's</h3>
    <p>Salbutamol 4mg/tablet
4mg x 100's pack: 33.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>D-BUTAMOL Syp. Doctor's</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 14.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DECABUTAMOL Syp. Decent Pharma</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 16.11 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DILATOL Syp. Chemico</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 15.90 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ETOL Syp. Edruc</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 15.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-SALBUTAMOL Tab. Gonoshastha</h3>
    <p>Salbutamol 4mg/tablet. 100's pack: 34.00 MRP.</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-SALBUTAMOL Syp. Gonoshastha</h3>
    <p>Salbutamol 2mg/5ml.: Syrup 100ml bot: 14.16 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-SALBUTAMOL Inj. Gonoshastha.</h3>
    <p>Salbutamol 50mcg/ml; 20ml vial: injection Dosage & Admin: See above under the text. 20ml vial x l's pack: 101.15 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>H-SELAX Tab. Hudson</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 34.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>H-SELAX Syp. Hudson</h3>
    <p>Salbutamol 2mg/5ml: syrup 60ml bot: 10.80 MRP 100m1 bot: 15.00 MRP +</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KOPTOLIN Tab. Skylab</h3>
    <p>Salbutamol 2mg & 4mg/tablet
2mg x 500's pack: 125.00 MRP
4mg x 200's pack: 66.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ORSAL Syp. Orion</h3>
    <p>Sulbutamol 2mg/5ml: syrup 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PULMOLIN Tab. Opsonin</h3>
    <p>Salbutamol 4mg/tablet
4mg x 100's pack: 33.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PULMOLIN Syp. Opsonin</h3>
    <p>Sulbutamol 2mg/5ml: syrup 60ml bot: 10.45 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESDIL Tab. Cosmo Pharma</h3>
    <p>Salbutamol 4mg/tablet 200's pack: 66.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESPOLIN Tab. Jayson</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 33.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESPOLIN Syp. Jayson</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 13.91 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULTOLIN-SR Tab. Square</h3>
    <p>Salbutamol 8mg/tablet (sustained release) 200's pack: 156.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULTOLIN Syp. Square</h3>
    <p>Salbutamol sulph. 2mg/5ml: syrup
100m1 bot: 15.68 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULTOLIN Inhaler (MDI) Square</h3>
    <p>Salbutamol 200mcg/puff or actuation; metered dose inhalation (MDI).
Dose: See above under the text.
200 dose unit: 130.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULTOLIN Cozycap Inhaler (DPI) Square</h3>
    <p>Salbutamol 200mcg/cozycap; dry powder inhalation (DPI).
Sultolin cozycap inhaler (DPI) is administered by cozyhaler device through oral inhalation route. Dosage: See above under the text.
200mcg x 30 caps pack: 39.90 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULTOLIN Respirator Soln. Square</h3>
    <p>Salbutamol sulphate 5mg/ml (i.e 0.5%) for use with a nebuliser or ventilator.</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOLIN Tab. Mystic</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 34.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOLIN Syp. Mystic</h3>
    <p>Salbutamol 2mg/5ml: syrup 100m1 bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENLET Syp. Apollo</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENOL Tab. Gaco</h3>
    <p>Salbutamol 2mg/tablet 100's pack: 26.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENOL SR Tab. Gaco</h3>
    <p>Salbutamol 8mg/tablet (sustained release)
100's pack: 75.53 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENOL Syp. Gaco</h3>
    <p>Salbutamol 2mg/5ml: syrup 60ml bot: 10.75 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTISAL Tab. Ibn Sina</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTISAL Syp. Ibn Sina</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 15.17 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOL Tab. CPL</h3>
    <p>Salbutamol 4mg/tablet 100's pack: 34.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOL Syp. CPL</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 15.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLEX-4 Tab. Desh</h3>
    <p>Salbutamol 4mg/tablet
500's pack: 170.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLEX Syp. Desh</h3>
    <p>Salbutamol 2mg/5ml: syrup 100ml bot: 16.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN Tab. GlaxoSmithKline</h3>
    <p>Salbutamol 2mg & 4mg/tablet. 2mg x 500's pack: 131.18 MRP 4mg x 500's pack: 171.59 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN Syp. GlaxoSmithKline</h3>
    <p>Salbutamol sulph. 2mg/5ml: syrup 100ml bot: 16.11 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN-SR Tab. GlaxoSmithKline</h3>
    <p>Salbutamol 8mg/tablet (sustained release)
250's pack: 194.11 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN Inhaler GlaxoSmithKline</h3>
    <p>200 dose unit: 165.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN Nebules GlaxoSmithKline</h3>
    <p>2.5mg (2.5ml) x 30's pack: 753.30 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>VENTOLIN Respirator Soln.</h3>
    <p>Salbutamol sulphate 5mg/ml (i.e 0.5%) for use with a nebuliser or ventilator.
Dose: See above
20ml pack: 172.25 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>WINDEL Tab. Incepta</h3>
    <p>Salbutamol 2mg & 4mg/tablet. 2mg x 200's pack: 52.00 MRP 4mg x 200's pack: 68.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>WINDEL Syp. Incepta</h3>
    <p>Salbutamol sulph. 2mg/5ml: syrup 100ml bot: 16.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZENTOLIN Syp. Zenith</h3>
    <p>Salbutamol sulph. 2mg/5ml: syrup 60m1 bot: 10.00 MRP
100ml bot: 15.60 MRP</p>   
</div><!-- collapsible -->


              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->




<!-- /................page............................ -->



<div data-role="page" id="Levosalbutamol" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Levosalbutamol   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> LEVOSALBUTAMOL: Tablet/Syrup/Inhaler  </h3>
          <p> LEVOSALBUTAMOL: Tablet/Syrup/Inhaler <br><br>
Levosulbutamol is a single isomer beta-2 agonist that differs from racemic sulbutamol by elimination of (S)-salbutamol. It is available as levosulbutamol sulphate INN equivalent to levosulbutamol 1mg & 2mg/tablet, 1mg/5ml of syrup & 50mcg/puff (inhalation). <br><br>

<strong>Mode of action:</strong> Levosulbutamol is an effective bronchodilator whose primary mechanism of action is unimpeded by (S)-salbutamol. Thus, when compared with racemic salbutamol, clinically comparable bronchodilatation can be achieved with doses that substantially lessen beta- mediated side effects. Levosulbutamol produces bronchodilatation through stimulation of beta-2- adrenergic receptors in bronchial smooth muscle, thereby causing relaxation of bronchial muscle fibres. <br><br>

<strong>Ind:</strong> Levosulbutamol is indicated for the treatment & prevention of bronchospasm in adults, adolescents, & children 6 yrs of age & older with reversible obstructive airway disease. C/I: History of hypersensitivity to levosulbutamol or any of its components. 
<br><br>

<strong>S/E:</strong> Hypocalcaemia, palpitation, fine tremors of the skeletal muscle & muscle cramps may occur. The other likely side effects are nausea, vomiting, burning substernal or epigastric pain & diarrhea. Precaution: Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia & by concomitant treatment with xanthine derivatives, steroids & diuretics. Serum potassium levels should be monitored in such situations. <br><br>

<strong>Pregnancy & lactation:</strong> The drug should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. It is not known whether levosulbutamol is excreted in human milk. So, caution should be exercised when oral levosulbutamol is administered to a nursing woman. <br><br>

<strong>Dosage & admin:</strong> Oral therapy: Adults & adolescents above 12 years: 1mg to 2mg, 3 times daily.
Children (6-11yrs)- 1mg (5m1) 3 times daily. By inhalation: Adults & children above the age of 4 years: For the relief of acute episodes of bronchospasm- 1 or 2 puffs as necessary; to prevent allergen or exercise induced bronchospasm- 2 puffs 15 minutes prior to exercise or exposure to allergen. The maximum dose is 8 puffs in 24 hours. <br><br>

<strong>Drug inter:</strong> Other short-acting sympathomimetic bronchodilators or epinephrine should be used with caution with levosulbutamol. If additional adrenergic drug are to be administered by any route, they should be used with cautoin to avoid deleterious cardiovascular effects.
   </p>
        </div><!-- collapsible -->



<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTISAL Tab. Silva </h3>
    <p>Levosalbutamol 1mg x 50's pack: 45.00 MRP 2mg x 50's pack: 85.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTISAL Syp. Silva</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
50ml bot: 25.00 MRP
100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AIRE Tab. Delta</h3>
    <p>1mg x 50's pack: 45.00 MRP 2mg x 50's pack: 85.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AIRE Syp. Delta</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
50m1 bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRIZY Tab. SK+F</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 50's pack: 42.50 MRP
2mg x 50's pack: 85.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRIZY Syp. SK+F</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup. 60m1 bot: 28.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROMOL Tab. Somatec</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 100's pack: 90.00 MRP
2mg x 100's pack: 170.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEBROD Tab. Alco Pharma</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet 1mg x 100's pack: 75.00 MRP
2mg x 100's pack: 140.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEBROD Syp. Alco Pharma</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
60m1 bot: 22.00 MRP
100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LESAL Tab. Apex</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 50's pack: 45.00 MRP
2mg x 50's pack: 75.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LESAL Syp. Apex</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
60m1 bot: 25.00 MRP
100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEVODIL Tab. Popular</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 100's pack: 90.00 IP
2mg x 100's pack: 170.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEVODIL Syp. Popular</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
100ml bot: 35.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEVOSTAR Tab. Square</h3>
    <p>Levosalbutamol sulphate INN equivalent to 2mg/tablet
2mg x 50's pack: 85.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEVOSTAR Syp. Square</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
50ml bot: 25.00 MRP
100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LEVOSTAR Inhaler Square</h3>
    <p>Levosalbutamol sulphate INN equivalent to 50mcg/puff or dose: metered dose inhalation (MDI).
Dosage & admin: See above under the text. 200 doses unit: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PURISAL Tab. Incepta</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 100's pack: 90.00 MRP
2mg x 100's pack: 170.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PURISAL Syp. Incepta</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
50ml bot: 25.00 MRP
100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PURISAL Nebuliser SoIn. Incepta</h3>
    <p>Levosalbutamol sulphate 0.63mg/3ml ampoule, & 1.25mg/3ml ampoule; for use with a nebuliser or ventilator. Dose: See above
0.63mg (3m1 amp) x 10's pack: 150.00 MRP 1.25mg (3ml amp) x 10's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESPIRA Tab. Beximco</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg & 2mg/tablet
1mg x 100's pack: 90.00 MRP
2mg x 100's pack: 170.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESPIRA Syp. Beximco</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
100ml hot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESPIRA Inhaler Beximco
100ml hot: 35.00 MRP</h3>
    <p>Levosalbutamol sulphate INN equivalent to 50mcg/puff or dose: metered dose inhalation (MDI).
Dosage & admin: See above under the text. 200 doses unit: 200.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TRULAX Syp. Renata</h3>
    <p>Levosalbutamol sulphate INN equivalent to 1mg/5ml: syrup.
100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->


              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->




<!-- /................page............................ -->



<div data-role="page" id="Terbutaline" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Terbutaline   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> TERBUTALINE: Tablet/Syrup  </h3>
          <p><strong>mode of action:</strong> Terbutaline is a
direct-acting sympathomimetic with predominantly beta-adrenergic activity and is a selective beta2-adrenergic receptor agonist used as bronchodilator. <br><br>

<strong>Ind:</strong> Bronchospasm in br. asthma, chronic bronchitis, status asthmaticus, emphysema. S/E & Cautions: See above under sulbutamol; premature labour. <br><br>

<strong>Dosage & admin:</strong> Use in bronchospasm: Adults- during the first 1-2 weeks 2.5mg 3 times daily is recommended. The dose may then be increased to 5mg 3 times daily to achieve adequate bronchodi-latation. Elderly- dosage as for adults. Children 7 to 15 years- the usual starting dose is 2.5mg 2 times daily; in some patients, the dose may need to be increased to 2.5mg 3 times daily.   </p>
        </div><!-- collapsible -->


<div data-role="collapsible"> <!-- collapsible -->
    <h3>TERVENT Tab. UniHealth</h3>
    <p>Terbutaline sulphate BP 2.5mg/tablet 100's pack: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TERVENT Syp. UniHealth</h3>
    <p>Terbutaline sulphate BP 1.5mg/5ml: syrup 100ml bot: 25.00 MRP</p>   
</div><!-- collapsible -->
  
      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->





<!-- /................page............................ -->



<div data-role="page" id="Bambuterol" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Bambuterol  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BAMBUTEROL HCI: Tablet/Syrup  </h3>
          <p> Bambuterol is an oral long-acting b2-agonist, used to treat symptoms of chronic bronchial asthma, particularly in patients who are unable to use inhaled products such as children and the elderly. Bambuterol is available as tablet and syrup. <br><br>

<strong>Mode of action:</strong> Bambuterol is a long-acting b2- agonist. It is a pro-drug of terbutaline that is slowly converted in the body to the active form, thus providing a prolonged action. <br><br>

<strong>Ind:</strong> Chronic bronchial asthma, specially for prevention of nocturnal symptoms; bronchospasn (breathing difficulties due to a narrowing of the airways); chronic obstructive airway disease. Bambuterol is not intended to treat acute asthma attacks. <br><br>

<strong>C/I:</strong> Cirrhosis and severe hepatic impairment. Hypersensitivity to bambuterol or any of its component. Avoid in children due to limited clinical data in this age group. <br><br>

<strong>S/E:</strong> Fine tremor, nervous tension, headache,
peripheral vasodilatation, palpitations, tachycardia, rarely muscle cramps; hypersensitivity reactions including paradoxical bronchospasm, urticaria, angioedema reported.  <br><br>

<strong>Precautions & warnings:</strong> Reduce the dose in renal impairment. Care should be taken with patients suffering from myocardial insufficiency or thyrotoxicosis. Due to the hyperglycaemic effects of b2-stimulants, additional blood glucose measurements are recommended initially when bambuterol therapy is commenced in diabetic patients. Due to positive inotropic effects of b2- agonists, these drugs should not be used in
patients with hypotrophic cardiomyopathy.  <br><br>

<strong>Pregnancy & lactation:</strong> There is no definite evidence of ill consequence during pregnancy. Nevertheless, the drug should not be used during the first trimester of pregnancy, unless the expected benefit is thought to outweigh any possible risk to the foetus. It is excreted in the breast milk, so patients taking this drug should not breast-feed. <br><br>

<strong>Dosage & admin:</strong> Adult- 20mg once daily at bedtime is effective if the patient has been previously tolerated with b2- agonists stimulants; other patients, initially 10mg once daily at bedtime, increased if necessary after 12 weeks to 20mg once daily.In elderly, dose adjustment is not required. In significant hepatic dysfunction, not recommended because of unpredictable conversion to terbutaline. <br><br>

<strong>Drug inter:</strong> Bambuterol inhibits plasma cholinesterases and can prolong the action of drugs such as suxamethonium that is inactivated by these enzymes. Bambuterol may partly or totally inhibit the effect of b-blockers.   </p>
        </div><!-- collapsible -->



<div data-role="collapsible"> <!-- collapsible -->
    <h3>AERODYL Tab. Silva</h3>
    <p>Bambuterol hydrochloride 10mg & 20mg/tablet 10mg x 100's pack: 150.00 MRP 20mg x 100's pack: 300.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AERODYL Syp. Silva</h3>
    <p>Bambuterol hydrochloride 5mg/5ml: syrup.
60m1 bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BAMBELOR Tab. Inecpta</h3>
    <p>Bambuterol hydrochloride 10mg & 20mg/tablet 10mg x 100's pack: 150.00 MRP 20mg x 100's pack: 300.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BUTEROL Tab. ACI</h3>
    <p>Bambuterol hydrochloride 10mg/tablet 10mg x 100's pack: 150.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BUTEROL Syp. ACI</h3>
    <p>Bambuterol hydrochloride 5mg/5ml: syrup.
100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DILATOR Tab. SK+F</h3>
    <p>Bambuterol hydrochloride 10mg & 20mg/tablet 10mg x 100's pack: 150.00 MRP
20mg x 100's pack: 300.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DILATOR Syp. SK+F</h3>
    <p>Bambuterol hydrochloride 5mg/5ml: syrup.
60ml bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUTEROL Tab. Acme</h3>
    <p>Bambuterol hydrochloride 10mg & 20mg/tablet 10mg x 100's pack: 150.00 MRP 20mg x 50's pack: 150.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUTEROL Syp. Acme</h3>
    <p>Bambuterol hydrochloride 5mg/5ml: syrup.
60ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Tulobuterol" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Tulobuterol   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>TULOBUTEROL HCI: Tablet/Syrup   </h3>
          <p> Tulobuterol, due to its highly selective action on the B2 adrenoceptors, relaxes the bronchial smooth muscles and has been shown to be clinically effective in the symptomatic treatment of reversible obstructive airway disease (ROAD), such as bronchial asthma and also in bronchitis and emphysema. <br><br>

<strong>Ind:</strong> Indicated in reversible airways obstruction & used in prophylaxis and control of bronchospasm in bronchial asthma, chronic bronchitis, asthmatic bronchitis, pulmonary emphysema, bronchiectasis, tracheo-bronchitis with bronchoconstriction, other bronchospastic disorders and conditions characterized by bronchoconstriction.Routine maintenance therapy in chronic asthma and bronchitis. <br><br>

<strong>S/E:</strong> Like other sympathomimetic agents tulobuterol can cause less frequent adverse reactions, such as hypertension, palpitation, angina, vomiting, vertigo, central nervous system stimulation, insomnia and headache. Cautions: Tulobuterol should be used with caution in patients with diabetes mellitus, hypertension and hyperthyroi-dism. Caution should be taken in cardiac patients, especially those with arrythmia and coronary insufficiency. <br><br> 

<strong>Pregnancy & Lactation:</strong> Safety of tulobuterol during pregnancy and lactation has not been established yet . It is not known whether tulobuterol is excreted in breast milk and or has a harmful effect to the new born. Therefore, prescription in such cases should be done considering the risk benefit ratio. <br><br>

<strong>Dosage & Admin:</strong> Adult, a convenient starting dose for adults and children of 12 years and over, is 1 mg twice daily. After 7-10 days of treatment, the dose should be increased to 2mg twice daily to achieve greater effect. Some patients however may require dosage adjustment and the adult dose may be increased upto 6mg daily when needed. Children, 6-10 years 0.5-1mg twice daily; over 10 years 1-2mg twice daily. (Who are supposed to take syrup- 1-6years, 1/4- 1/2 tsf twice daily; 6-12 years, 1/2-1 tsf twice daily).
The above recommended dosage may have to be modified depending upon the patient response.   </p>
        </div><!-- collapsible -->




<div data-role="collapsible"> <!-- collapsible -->
    <h3>BREMAX Tab. Abbott/UniHealth</h3>
    <p>Tulobuterol hydrochloride 2mg/tablet 100's pack: 372.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRETON Tab. Drug Inter.</h3>
    <p>Tulobuterol hydrochloride 2mg/tablet 100's pack: 250.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRETON Syp. Drug Inter.</h3>
    <p>Tulobuterol hydrochloride 1mg/5ml: syrup 60m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->


              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->




<!-- /................page............................ -->



<div data-role="page" id="Long-acting selective" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Long-acting selective   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> SALMETEROL  </h3>
          <p> SALMETEROL XINAFOATE: Metered dose inhalation (MDI)/Dry powder inhalation (DPI) It is a long-acting b2- adrenoceptor stimulant. It is usually not used for the relief of an acute attack, but added to existing corticosteroid and/or sodium cromoglycate therapy and not replace it. <br><br>

<strong>Ind:</strong> Reversible airways obstruction (including nocturnal asthma and prevention of exercise- induced bronchospasm) in patients requiring long- term regular bronchodilator therapy, who should normally also be receiving regular and adequate doses of inhaled anti-inflammatory drugs (e.g corticosteroids and/or in children, sodium cromoglycate) or oral corticosteroids. <br><br>

<strong>S/E:</strong> Cautions: See under salbutamol; important: significant incidence of paradoxical bronchospasm, which may be clinically important in severe or deteriorating asthma. <br><br>

<strong>Dosage & admin:</strong> Metered dose inhalation (25mcg/puff or dose): By inhalation, 50mcg (2 puffs) twice daily; up to 100 mcg (4 puffs) twice daily in more severe airways obstruction. Children: Under 4 years, not recommended, over 4 years, 50mcg (2 puffs) twice daily.Dry powder inhalation (50mcg/puff or dose): By inhalation, 50mcg (1 puff) twice daily; up to 100mcg (2 puffs) twice daily in more severe airways obstruction. Children: Under 4 years, not recommended, over 4 years, 50mcg (1 puff) twice daily.   </p>
        </div><!-- collapsible -->




<div data-role="collapsible"> <!-- collapsible -->
    <h3>AXINAT Inhaler (MDI) Acme</h3>
    <p>120 doses unit: 125.00 MRP 200 doses unit: 175.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BEXITROL Inhaler (MDI) Beximco</h3>
    <p>Dosage & admin: See above under the text. 120 inhalations unit: 190.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SALMATE Inhaler (MDI) Square</h3>
    <p>Dosage & admin: See above under the text. 200 doses unit: 190.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SALMEROL 50 Inhaler (DPI) Acme</h3>
    <p>Salmerol inhaler (DPI) is administered by Rotahaler device through oral inhalation route. Dosage & admin: See above under the text. 30 doses unit: 60.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Other adrenoceptor stimulants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Other adrenoceptor stimulants   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> ADRENALINE: Injection/Inhaler  </h3>
          <p> <strong>Ind:</strong> Bronchospasm, chronic bronchitis; emergency treatment of acute anaphylaxis. <br><br>
<strong>C/I:</strong> Hyperthyroidism, hypertension, coronary disease <br><br>
<strong>S/E:</strong> Anxiety, tremor, tachycardia, cardiac arrhythmias.
Cardiac disease; diabetes; should not be used within 2 wks. of MAO inhiitors. Not to be given intravenously because of increased risk of cardiac irregularities. <br><br>
<strong>Dose:</strong> Bronchospasm, as a single dose by s.c. or i.m or by oral inhalation of nebu-lised solution, 200-500 mcg. by aerosol inhalation, 280-560 mcg. ( 1-2 puffs) upto 3-4 times daily.
Acute anaphylaxis, by s.c. or i.m injection, 0.5- 1mg.   </p>
        </div><!-- collapsible -->


<div data-role="collapsible"> <!-- collapsible -->
    <h3>ADRENALINE Inj. Waldamar</h3>
    <p>Adrenaline 1mg in 1ml (1: 1000) ampoule: injection 100's pack: 236.15 MRP
N.B: Price could not be revised.</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ADRENALINE Inj. Pharmachim</h3>
    <p>Adrenaline 1mg in 1ml (1: 1000) ampoule: injection 100's pack: 266.20 MRP
Preparation: May not be available</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ADRINE Inj. Gaco</h3>
    <p>Adrenaline 1mg in 1ml (1: 1000) ampoule: injection
1 ampoule: 5.00 MRP</p>   
</div><!-- collapsible -->

      </div><!-- collapsible-set -->


      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> EPHEDRINE HCI: Tablet/Syrup/ Drop/Injection  </h3>
          <p>  Ind: Bronchospasm, nasal congestion. <br><br>
C/I: Hyperthyroidism, hypertension, coronary disease, renal impairulent. <br><br>
S/E: Tremor, tachycardia, insomnia, urinary retention, dry moulh cold extremities. <br><br>
Caution: Cardiac diseases, diabetes. Should not be given within 2 wks. of MAO inhibitors. Adult: By mouth, 15-60mg 3 times daily Child: upto 1 yr. 7.5 mg; 1-5yrs, 15mg; 6-12yrs. 30 mg; all 3 times daily.  </p>
        </div><!-- collapsible -->



<div data-role="collapsible"> <!-- collapsible -->
    <h3>EPHEDRINE Syp. Elixir</h3>
    <p>Ephedrine hydrochloride 15mg/5ml: syrup 100ml bot: 26.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FEDRIN Tab. Jayson</h3>
    <p>Ephedrine hydrochloride 30mg/tablet 1000' pack: 250.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FEDRIN Inj. Jayson Ephedrine</h3>
    <p>hydrochloride 25mg/5ml ampoule: injection 10 amps pack: 120.00 IP </p>   
</div><!-- collapsible -->

        
        </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->




<!-- /................page............................ -->



<div data-role="page" id="Antimuscarinic bronchodilators" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Antimuscarinic bronchodilators   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<p> Antimuscarinic bronchodilators are more effective in chronic obstructive pulmonary disease rather than in relieving asthma. Ipratropium & oxitropium may be used by inhalation in the management of chronic asthma in patients who already require high-dose inhaled corticosterodis. Ipratropium by nebulisation may be added to other standard treatment in life threatening asthma or where acute asthma fails to improve with standard therapy.
Tiotropium is a long-acting, antimuscarinic agent, which is often referred to as an anticholinergic. It has similar affinity to the subtypes of muscarinic receptors. It is indicated for the long-term, once- daily approach to manage and maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.</p>


      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> IPRATROPIUM BROMIDE: Oral inhalation  </h3>
          <p> <strong>Mode of action:</strong> Ipratropium bromide is a synthetic quaternary anti-cholinergic
parasympatholytic ammonium compound, chemically related to atropine which appears to inhibit vagally mediated reflexes by antagonizing the action of acetylcholine- the neurotransmitter released by the vagus nerve. It is a competitive antagonist at the muscarinic acetylcholine receptors. Anti-cholinergics prevent the increases in intracellular concentration of cyclic GMP which are caused by interaction of acetylcholine with the muscarinic receptors on bronchial smooth muscle. The bronchodilation following oral inhalation of ipratropium bromide is primarily a local, site-specific effect, not a systemic one.  <br><br>

<strong>Ind:</strong> As bronchodilator in treatment of chronic reversible airway obstruction as in asthma and chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. Treatment of acute reversible airways obstruction. Ipratropium bromide inhalation aerosol is not indicated for the initial treatment of acute episodes of bronchospasm where rapid response is required. <br><br>

<strong>C/I:</strong> Konwn hypersensitivity to ipratropium bromide, atropine or its derivative. Also contraindicated in patients with a history of hypersensitivity to soya lecithin or related food products such as soybean, lecithin and peanut.  <br><br>

<strong>S/E:</strong> Idiosyncratic reactions to ipratropium bromide are rare. Severe adverse effects due to inhibition of muscarinic receptors and ganglion blockade are theoretically possible but unlikely with the metered-dose aerosol.Regular use of ipratropium can lead to a dry mouth through inhibition of salivary flow. Other common adverse reactions reported are- dryness of the mouth & oropharynx, nausea, dizziness, blurred vision/difficulty in accommodation & drying of secretions.Less frequently reported adverse reactions include tachycardia, nervousness, paresthesia, drowsiness, co-ordination difficulty, itching, hives, flushing, alopecia, constipation, tremor & mucosal ulceration.Case of precipitation or worsening of narrow- angle glaucoma, acute eye pain & hypotension also have been reported.
Allergic-type reactions such as skin rash, angio- oedema of tongue, lips & face, urticaria (including giant urticaria), laryngospasm and anaphylactic reaction have also been reported; with positive rechallenge in some cases. Ipratropium bromide does not produce adverse effects on mucocilliary clearance, in contrast to atropine and other muscarinic antagonists. There is no evidence that in the therapeutic dose range ipratropium bromide has any adverse effect on bronchial secretion. Precaution: Patients should be advised that temporary blurring of vision, precipitation or worsening of narrow angle glaucoma or eye pain may result if the aerosol is sprayed into the eyes. If recommended dosage does not provide relief or symptoms become worse, patients should seek immediate medical attention. While taking ipratropium bormide inhalation aerosol, other inhaled drugs should not be used unless prescribed.Immediate hypersensitivity reactions may occur after administration of ipratropium bromide, as demonstrated by rare cases of urticaria,
angiooedema, rash, bronchospasm and oropharyngeal oedema. <br><br>

<strong>Dosage & admin:</strong> For oral inhalation only. Adults- the usual dose is 1-2 puffs/spray 3 or 4 times daily. Single dose up to 80mcg (4 puffs or spray of 20mcg/puff or 2 puffs of 40mcg/puff) may be required to obtain maximum benefit during early treatment. Patients may take additional inhalations as required; however, the total number of oral inhalations should not exceed 12 puffs (20mcg/puff) or 6 puffs (40mcg/puff) in 24 hours.
Children- 6 to 12 years- usually 1-2 puffs or spray (20mcg/puff) 2 to 3 times daily. Below 6 years- the usual dose is 1 puff or spray (20mcg) 3 times daily. In order to ensure that the inhaler is used correctly, administration should be supervised by an adult.
On clinical trials, no specific information & adverse reactions on the use of the product in the elderly is available.
Drug inter: Ipratropium bromide has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, steroids and cromolyn sodium, commonoy used in treatment of COPD, without any adverse drug reactions.   </p>
        </div><!-- collapsible -->
       

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CYCLOVENT Inhalar Pharmachemie, B.V/
City Overseas</h3>
    <p>Cyclovent cyclocap is administered by cyclohaler through oral inhalation route. Rinsing the mouth after inhalation is advised. 40mcg x 100 cyclocaps pack: 350.00 TP
Price of Cyclohaler (Ps): 125.00 TP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-IPRA Respirator Soln. Gonoshasthaya</h3>
    <p>Ipratropium bromide 250mcg/ml: Respirator solution for inhalation.
20ml vial: 60.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>IPRAMID Inhalar Beximco</h3>
    <p>Ipratropium bromide 20mcg/puff (spray): oral inhalar.
Each canister of Ipramid inhaler contains 4mg of ipratropium bromide BP.
200 puffs inhalar: 200.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>IPREX Inhalar Square</h3>
    <p>Ipratropium bromide 20mcg/puff (spray): oral inhalar.
Each canister of Iprex inhaler contains 4mg of ipratropium bromide BP.
200 puffs inhalar: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>IPREX Respirator SoIn. Square</h3>
    <p>Ipratropium bromide 250mcg/ml: Respirator
solution for inhalation. 20ml pack: 130.00 MRP</p>   
</div><!-- collapsible -->



      </div><!-- collapsible-set -->


      <div data-role="collapsible-set" data-theme="a">

         <div data-role="collapsible"> <!-- collapsible -->
          <h3>TIOTROPIUM BROMIDE: DPI/MDI  </h3>
          <p> Tiotropium is a long-acting antimuscarinic bronchodilator. It is available as dry powder inhalation (DPI) & metered dose aerosol inhalation (MDI).
DPI: Tiotropium bromide monohydrate INN 18mcg/Rotacap. Dry powder inhalation is for oral inhalation only.
MDI: Tiotropium bromide monohydrate INN 9mcg/ puff; Metered dose aerosol inhalation (MDI). Ind: Tiotropium bromide is indicated for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. <br><br>

<strong>Mode of action:</strong> Tiotropium is a long-acting, antimuscarinic agent, which is often referred to as an anticholinergic. It has similar affinity to the subtypes of muscarinic receptors, M1 to M5. In the airways, it exhibits it's effects through inhibition of M3-receptors at the smooth muscle leading to bronchodilation. The bronchodilation following inhalation of tiotropium is predominantly a site-specific effect. <br><br>

<strong>C/I:</strong> Tiotropium is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, including ipratropium, or to any component of the product.
Precaution: As an anticholinergic drug, tiotropium may potentially worsen symptoms and signs associated with narrow-angle glaucoma, prostatic hyperplasia or bladder neck obstruction and should be used with caution in patients with any of these conditions. As a predominantly renally excreted drug, patients with moderate to severe renal impairment treated with tiotropium should be monitored closely. Eye pain or discomfort, blurred vision, visual halos or colored images in congestion and corneal edema may be signs of acute narrow angle glaucoma. Should any of these signs and symptoms develop, consult a physician immediately. Miotic eye drops alone are not considered to be effective treatment. <br><br>

<strong>S/E: </strong>The most commonly reported adverse reaction was dry mouth; it was usually mild and often resolved during continued treatment. Other reactions reported include constipation, increased heart rate, blurred vision, glaucoma, urinary difficulty, and urinary retention. <br><br>

<strong>Pregnancy & lactation:</strong> Tiotropium should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The safety and effectiveness of tiotropium has not been studied during labor and delivery. Clinical data from nursing women exposed to tiotropium are not also available, so, caution should be exercised if tiotropium is administered to a nursing mother. Dosage & admin: Metered dose inhalation (MDI): Adults and adolescents 12 years & older: The recommended dosage of tiotropium bromide is the inhalation of 2 puffs (9mcg/puff) once daily for the maintenance treatment of bronchospasm associated with COPD. No adjustment of tiotropium dosage in geriatric patients is warranted. Children below 12 years: Not recommended. MDI or Metered dose inhaler is to be used by aerosol inhalation only. <br><br>

<strong>Dry powder inhalation (DPI):</strong>
Adults and adolescents 12 years & older: The recommended dosage of tiotropium bromide is the inhalation of 1 Rotacap (18mcg/Rotacap) once daily for the maintenance treatment of bronchospasm associated with COPD. No adjustment of tiotropium dosage in geriatric patients is warranted.
Children below 12 years: Not recommended. DPI or Dry powder inhalation is for oral inhalation only. Rotahaler device is used for dry powder inhalation.
Rinsing the mouth after dry powder inhalation is advised. <br><br>

<strong>Drug inter:</strong> Tiotropium has been used concomitantly with other drugs commonly used in COPD without increases in adverse drug reactions. These include sympathomimetic bronchodilators, methylxanthines, and oral and inhaled steroids. However, the co-administration of tiotropium with other anticholinergic- containing drugs (e.g ipratropium) has not been studied and is therefore not recommended.   </p>
         </div><!-- collapsible -->


<div data-role="collapsible"> <!-- collapsible -->
    <h3>NORVENT Inhaler (MDI) Square</h3>
    <p>Tiotropium bromide monohydrate INN 9mcg/puff: Metered dose inhalation (MDI).
120 puffs unit: 500.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOPIUM Inhaler (DPI) Acme</h3>
    <p>Tiotropium bromide monohydrate INN 18mcg/Rotacap: Dry powder inhalation (DPI). 30 Rotacaps pack: 150.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TRIOMID Inhaler (MDI) Beximco</h3>
    <p>Tiotropium bromide monohydrate INN 9mcg/puff: Metered dose inhalation (MDI).
120 puffs unit: 500.00 MRP</p>   
</div><!-- collapsible -->

              

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Theophylline & related drugs" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Theophylline & related drugs  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<ul data-role="listview" data-inset="true" data-theme="b">        
     
       
        <li><a href="#Aminophylline">Aminophylline</a></li> 
        <li><a href="#Theophylline">Theophylline</a></li> 
       
          
</ul>


   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Aminophylline" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Aminophylline   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> AMINOPHYLLINE: Tablet/Injection/ Suppos.  </h3>
          <p> Aminophylline BP is a stable mixture or combination of theophylline and ethylenediamine. Ethylenediamine confers greater solubility in water. 

<strong>Ind:</strong> It is indicated for the treatment & prophylaxis of bronchospasm associated with asthma, emphysema and chronic bronchitis. Also indicated in adults for the treatment of cardiac asthma & left ventricular or congestive cardiac failure. <br><br>

<strong>C/I:</strong> Aminophylline should not be administered to. 
patients with hypersensitivity to xanthines or ethylenediamine. It should not be administered to patients with active peptic ulcer, since it may increase the volume & acidity of gastric secretions.  <br><br>

<strong>S/E:</strong> The most common adverse effects are gastric
￼irritation, nausea, vomiting, epigastric pain and tremor. These are usually early signs of toxicity; however, with high doses, ventricular arrhythmias or seizures may be the first signs to appear. Adverse reactions include: gastrointestinal symptoms- such as nausea, vomiting, epigastric pain, hematemesis, diarrhoea, anorexia, intestinal bleeding and reactivation of peptic ulcer; CNS symptoms- headache, irritability, restlessness, insomnia, twitching, convulsion and reflex hyperexcitability; Cardiovascular symptoms- palpitation, tachycardia, hypotension, circulatory failure, ventricular arrhythmias, and flushing; Renal symptoms- albuminuria, diuresis and hematuria; Others- hyperglycemia, tachypnea and inappropriate ADH syndrome. <br><br>

<strong>Precautions:</strong> Aminophylline should be given with caution to patients with peptic ulceration, hyperthyroidism, hypertension, cardiac arrhythmias or other cardiovascular diseases, or epilepsy, as these conditions may be exacerbated. It should also be given with caution to patients with heart failure, hepatic dysfunction, chronic alcoholism, acute febrile illness, and to neonates and the elderly, since in all of these circumstan ces theophylline clearance may be decreased, resulting in increases in serumtheophylline concentrations and serum half-life. <br><br>

<strong>Pregnancy & lactation:</strong> Theophylline crosses the placental barrier and also passes freely into breast milk, where concentrations are similar to plasma levels. Safe use in pregnancy has not been established relative to possible adverse effects on fetal development. Therefore, use of aminophylline in pregnant women should be weighed against the risk of uncontrolled disease.<br><br>

<strong>Dosage:</strong> By mouth: Adult, initially
100-200mg 2-3 times daily for one week, then maintenance 200-600mg twice daily. Child, under 1 year not recommended; over 1 year 12mg/kg body-wt. twice daily.
Special tablet preparations (LA/Rtd/SR tablet):
See below under individul product. <br><br>

<strong>Note:</strong> Tablets should be swallowed whole & not chewed because of the structure of the tablet. By injections: Adult, 125-250mg by slow (over 10-15 mins) i.v injection, usually given in 5% dextrose in aqua or normal saline. (rapid injection may result in cardiac arrest). Children, 2-3mg/kg 2-3 times daily by very slow i.v injection.
By rectum in suppositories: Adult, 360mg once or twice daily. Child, once or twice daily, upto 1 yr. 12.5-25mg; 1-5 yrs. 50-100mg; 6-12 yrs. 100- 200mg. <br><br>

<strong>Drug inter:</strong> Beta-blockers (e.g propranolol) may oppose the effects of aminophylline. Barbiturates, phenytoin and smoking may decrease theophylline levels in blood or circulation.   </p>
        </div><!-- collapsible -->
  



<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOMAL-R SR Tab. Malesci/Pacific</h3>
    <p>Dosage: 1/2-1 tablet every 12 hours, unless otherwise directed by the doctor. Administration on a full stomach is advised. 20's pack: 392.60 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOPHYLLINE Tab. Ambee</h3>
    <p>Aminophylline 100mg/tablet 500's pack: 190.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOPHYLLINE Inj. Ambee</h3>
    <p>Aminophylline 125mg/5ml ampoule: injection 5 amps pack: 27.25 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOPHYLLINE Tab. Bristol</h3>
    <p>Aminophylline 100mg/tablet
200's pack: 190.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOPHYLLINE Tab. Chemist</h3>
    <p>Aminophylline 100mg/tablet
500's pack: 190.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMINOPHYLLINUM Rtd. Tab. Novartis</h3>
    <p>Aminophylline 350mg/tablet (retard)
Dosage & admin: The recommended initial dose is 1 tablet (350mg) every 12 hours. The dosage may be gradually increased to a maximum of 2 tablets (700mg) twice a day depending on the patientis response.
50's pack: 111.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLIN Rtd. Tab. Delta</h3>
    <p>Aminophylline 350mg/tablet (retard)
Dosage & admin: The recommended initial dose is 1 tablet (350mg) every 12 hours. The dosage may be gradually increased to a maximum of 2 tablets (700mg) twice a day depending on the patientis response.
50's pack: 110.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FILIN Tab. Opsonin</h3>
    <p>Aminophylline 100mg/tablet
100's pack: 38.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FILIN Inj. Opsonin</h3>
    <p>Aminophylline 125mg/5ml ampoule:injection 10 amps pack: 44.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LARNOX-LA Tab. Beximco</h3>
    <p>350mg x 50's pack: 110.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MINOMAL R Tab. Pacific</h3>
    <p>175mg x 100's pack: 123.00 MRP
350mg x 50's pack: 110.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MINOMAL-R SR Tab. Pacific</h3>
    <p>Aminophylline dihydrate 600mg/tablet (sustained release).
Dosage: 1/2 -1 tablet every 12 hours, unless otherwise directed by the doctor. Administration on a full stomach is advised. 20's pack: 71.80 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RESTOPHYLLINE Tab. Gaco</h3>
    <p>Aminophylline 100mg/tablet 100's pack: 38.43 MRP</p>   
</div><!-- collapsible -->

      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Theophylline" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Theophylline    </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> THEOPHYLLINE Sodium Glycinate: Tablet/Capsule/Syrup  </h3>
          <p> Structurally theophylline is a xanthine derivative. It is available in tablet, capsule & syrup form. Mode of action: Theophylline is a bronchodilator. It directly relaxes the smooth muscle of the bronchial airways, pulmonary airways and pulmonary blood vessels. <br><br>

<strong>Ind:</strong> Theophylline is indicated for relief and/or prevention of symptoms from asthma and reversible bronchospasm associated with chronic bronchitis and emphysema. <br><br>

<strong>C/I:</strong> Known hypersensitivity to its components; patients with active peptic ulcer disease. <br><br>

<strong>S/E:</strong> The following side effects have been observed: Nausea, vomiting, epigastric pain and diarrhoea; Headache, irritability, restlessness, insomnia, muscles twitching; Palpitation, tachycardia, hypotension, circulatory failure; Tachypnoea; Potentiation of diuresis. Others: Alopecia, hyperglycemia, rash etc. <br><br>

<strong>Precautions:</strong> Theophylline should not be administered concurrently with other xanthine. Use with caution in patients with hypoxemia, hypertension, or those with history of peptic ulcer. Do not attempt to maintain any dose that is not tolerated. <br><br>

<strong>Pregnancy & lactation:</strong> It is also not known whether theophylline can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Xanthine should be given to a pregnant woman only if clearly needed. Theophylline is excreted into breast milk and may cause irritability or other signs of toxicity in nursing infants. So, it should be given to nursing mother only if clearly needed. <br><br>

<strong>Dosage & admin:</strong> Dosages are adjusted to maintain serum theophylline concentrations that provide optimal relief of symptoms with minimal side effects. The recommended dosages for achieving serum theophylline concentrations within the accepted therapeutic range are as following:
Adult: 125-250mg 3-4 times daily.
Children: 1-6 months, 10mg/kg/day; 6 months- 1 year 15mg/kg/day; 1-9 years, 24mg/kg/day; 10-16 years, 18mg/kg/day, in 3-4 divided doses.  <br><br>

<strong>Drug inter:</strong> Allopurinol, cimetidine, ciprofloxacin, erythromycin, lithium carbonate, oral contraceptive, propranolol increases serum theophylline level when administered concomitantly and rifampicin decreases serum theophylline level.
Note: 2 gm of theophylline sodium glycinate is approximately equivalent to 1.1 gm theophylline anhydrous.   </p>
        </div><!-- collapsible -->
  

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AROFIL 300 SR Tab. Incepta</h3>
    <p>Theophylline sodium glycinate 300mg/tablet. (sustained release). 50's pack: 100.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AROFIL 400 SR Tab. Incepta</h3>
    <p>Theophylline sodium glycinate 400mg/tablet. (sustained release).50's pack: 133.50 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASMACON SR Tab. Pacific</h3>
    <p>Theophylline sodium glycinate 400mg/tablet. (sustained release).50's pack: 130.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASMAIN Syp. Edruc</h3>
    <p>Theophylline sodium glycinate 120mg/5ml: syrup 100ml bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ASMANYL 300 SR Tab. Square</h3>
    <p>Theophylline sodium glycinate 300mg/tablet. (sustained release). 100's pack: 196.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CONTINE Syp. Aristopharma</h3>
    <p>Theophylline sodium glycinate 120mg/5ml: syrup 100ml but: 23.77 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-THEOPHYLLINE Tab. Gonoshastha</h3>
    <p>Theophylline sodium glycinate 300mg/tablet 100's pack: 81.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>G-THEOPHYLLINE Syp. Gonoshastha</h3>
    <p>Theophylline sodium glycinate 120mg/5ml: syrup 100m1 bot: 13.70 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>JASOPHYLIN Tab. Jayson</h3>
    <p>Theophylline sodium glycinate 300mg/tablet 100's pack: 126.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>JASOPHYLIN Syp. Jayson</h3>
    <p>Theophylline sodium glycinate 120mg/5ml: syrup 100m1 bot: 22.25 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NEONATE Syp. Skylab</h3>
    <p>Theophylline sodium glycinate 150mg/5ml: syrup 50ml bot: 13.70 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THENGLATE SR Tab. Acme</h3>
    <p>Theophylline sodium glycinate 250mg & 400mg/tablet. (sustained release). 250mg x 50's pack: 75.00 MRP
400mg x 50's pack: 133.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THENGLATE Syp. Acme</h3>
    <p>Theophylline sodium glycinate 120mg/5ml: syrup 100ml bot: 23.77 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEOGLATE Syrup CPL</h3>
    <p>Theophylline sodium glycinate 150mg/5ml: syrup 50ml bot: 12.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEONATE Tab. Doctors.</h3>
    <p>Theophylline sodium glycinate 300mg/tablet. 100's pack: 131.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEONATE SR Tab. Doctors.</h3>
    <p>Theophylline sodium glycinate 300mg/tablet. (sustained release).
40's pack: 116.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEONATE Syp. Doctors</h3>
    <p>Theophylline sodium glycinate 150mg/ 5ml: syrup.50ml bot: 15.20 MRP
100ml bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEOVENT Cap. Drug Inter.</h3>
    <p>Theophylline sodiun glycinate 300mg/capsule (sustained release).
100's pack: 292.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THEOVENT SR Tab. Drug Inter.</h3>
    <p>Theophylline sodium glycinate 400mg/tablet. (sustained release).
50's pack: 133.50 MRP</p>   
</div><!-- collapsible -->



      </div><!-- collapsible-set -->


   <div data-role="collapsible-set" data-theme="a">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> THEOPHYLLINE ANHYDROUS: Tablet/Capsule  </h3>
          <p> <strong> Ind:</strong> Bronchospasm associated with asthma, ch. bronchitis, emphysema. <br><br>

<strong>C/I; S/E; Cautions:</strong> See above under the text of 'theophylline sodium glycinate'.

<strong>Pregnancy & lactation:</strong> See above under the text of 'theophylline sodium glycinate'.

<strong>Dosage:</strong> Adult, over 50kg 250-300mg (1tab.) twice daily in the morning & evening. Adults with low body weight & adolescents, half the
adult dose (1/2 tab.) 2-3 times daily.

<strong>Children:</strong> 10-15mg/kg given in 2 divided doses at 12 hours intervals. It is better taken after meals with a little water. It is suitable for longterm administration.

<strong>Drug inter:</strong> See above under the text of 'theophylline sodium glycinate'.  </p>
        </div><!-- collapsible -->
  


<div data-role="collapsible"> <!-- collapsible -->
    <h3>CONTINE-400 Tab. Aristopharma</h3>
    <p>Theophylline anhydrous 400mg/tablet (in continuous controlled release system).
Dose: See above under the text; but instead of two times, give once daily.
100's pack: 267.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EUPHYLLIN Rtd. Tab. BYK Gulden/Swadesh</h3>
    <p>Theophylline anhydrous 250mg/tablet (retard). 100's pack: 702.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>QUIBORN-T/SR Tab. Squibb/ Kapricorn</h3>
    <p>Theophylline anhydrous 300mg/tablet (timed/sustained release).
100's pack: 546.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SPOPHYLLIN Rtd. Tab. Zentiva/City Overseas</h3>
    <p>Theophylline anhydrous 250mg/tablet (retard). 50's pack: 170.00 TP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>THENGLATE TR Cap. Acme</h3>
    <p>Theophylline anhydrous 300mg/capsule (timed release).
100's pack: 293.00 MRP</p>   
</div><!-- collapsible -->

      </div><!-- collapsible-set -->
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Compound bronchodilator prepns" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Compound bronchodilator prepns  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> SALBUTAMOL + IPRATROPIUM BROMIDE: Metered dose inhalation (MDI)  </h3>
          <p>  This is a combined metered dose inhalation formulation of two components- salbutamol, a b2 adrenergic bronchodilator and ipratropium bromide, an anti-cholinergic bronchodilator. Each single actuation of this inhalation aerosol delivers 20mcg of ipratropium bromide BP and 100mcg of salbutamol BP. <br><br>

<strong>Ind:</strong> This combined inhalation aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator. <br><br>

<strong>C/I:</strong> See above under the text of 'salbutamol' & 'ipratropium bromide' separately. <br><br>

<strong>S/E:</strong> Precautions: See above under the text of 'salbutamol' & 'ipratropium bromide' separately. Pregnancy & lactation: There are no adequate and well-controlled studies of salbutamol & ipratropium bromide combination inhalation aerosol in pregnant women. So, the use of this - combination aerosol product for the treatmnt of COPD during pregnancy and labor should be restricted to those patients in whom the benefits clearly outweigh the risk to the fetus.
It is not known whether the components of salbutamol & ipratropium bromide combination inhalation aerosol are excreted in human milk. However, because many drugs are excreted in human milk, caution should be exercised when salbutamol & ipratropium bromide combination inhalation aerosol is administered to a nursing mother. <br><br>

<strong>Dosage & admin:</strong> Adults (including the elderly and adolescents over 12 years of age): The dose of this combined inhalation aerosol is 2
puffs 4 times a day. Patients may take
additional inhalations as required; however, the total number of inhalations should not
exceed 12 in 24 hours. 
Children (below 12 years): Not recommended.  </p>
        </div><!-- collapsible -->
  


<div data-role="collapsible"> <!-- collapsible -->
    <h3>IPRASOL Inhaler (MDI) Beximco</h3>
    <p>Each single actuation of this inhalation aerosol delivers 20mcg of ipratropium bromide BP and 100mcg of salbutamol BP.200 puffs unit: 230.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SALPIUM Inhaler (MDI) Acme</h3>
    <p>Each single actuation of this inhalation aerosol delivers 20mcg of ipratropium bromide BP and 100mcg of salbutamol BP.200 puffs unit: 230.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SULPREX Inhaler (MDI) Square</h3>
    <p>Each single actuation of this inhalation aerosol delivers 20mcg of ipratropium bromide BP and 100mcg of salbutamol BP.
200 puffs unit: 225.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->



<div data-role="page" id="Cromoglycate & Related drugs" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Cromoglycate & Related drugs   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

 <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> SODIUM CROMOGLYCATE: Aerosol/Spray  </h3>
          <p> 
<strong>Mode of action:</strong> Sodium cromoglycate is an antiasthmatic, antiallergic and mast cell stabilizer. It has no intrinsic bronchodilator, antihistaminic, vasoconstrictor or anti-inflammatory activity. It prevents release of the mediators of type-1 allergic reactions, including histamine and slow reacting substance of anaphylaxis (SRS-A) from sensitized mast cells after the antigen-antibody reaction has taken place. The drug does not inhibit the binding of IgE to mast cells, nor the interaction between cell bound IgE and the specific antigen; instead, sodium cromoglycate suppresses the release of substances (e.g histamine, SRS-A) in response to this reaction. The drug also inhibits type-III (late allergic, arthus) reactions to a lesser extent. The action of sodium cromoglycate on the mast cell is not restricted to antigen-evoked secretion, since the drug has also been shown to inhibit secretion induced by other mast cell secretagogues (e.g the polyamine 48/80). Bronchial asthma induced by the inhalation of antigens can be inhibited to varying degrees by sodium cromoglycate pre-treatment.Sodium cromoglycate acts locally on the lungs to which it is directly applied by inhalation.

<strong>Ind:</strong> Prophylaxis of bronchial asthma; prevention of exercise-induced asthma. Children seem to response better than adults.
It has no value in the treatment of acute attack of asthma.

<strong>C/I:</strong> Patients who have shown hypersensitivity to sodium cromoglycate or to any of its components. It is not indicated as the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. S/E: Coughing, transient bronchospasm & throat irritation due to inhalation of powder. 

<strong>Precautions:</strong> The recommended dosage should be decreased in patients with renal or hepatic dysfunction.
Where a concomitant bronchodilator is prescribed, it is recommended that this be administered prior to the sodium cromoglycate inhalation.
In patients currently treated with steroids, the addition of sodium cromoglycate inhalation to the regimen may make it possible to reduce the maintenance dose or to discontinue steroid completely. The patient must be carefully supervised while the steroid dose is reduced; a rate of reduction of 10% weekly is suggested. If reduction of steroid dosage is possible, sodium cromoglycate inhalation should not be withdrawn until steroid cover has heen re-instituted.
Since the therapy is prophylactic, it is important
to continue therapy in those patients who get benefit. If it is necessary to withdraw this treatment, it should be done gradually over a period of one week.

<strong>Pregnancy & lactation:</strong> As with all medication, caution should be exercised specially during the first trimester of pregnancy. Cumulative experience with sodium cromoglycate suggests that it has no adverse effects on foetal development. However, it should only be used in pregnancy where there is a clear need.
It is not known whether sodium
cromoglycate is excreted in the breast milk, there is also no evidence that the use of sodium cromoglycate has any undesirable effects on the breast-fed baby.  <br><br>

<strong>Dose:</strong> By aerosol inhalation, adults & children- 10mg (or 2 puffs) 4 times daily initially at regular intervals in spinhaler, increasing in severe cases or duringperiods of risk to 6-8 times daily. Before exercise, additional doses may be taken. Maintenance, 5mg(1 puff) 4 times daily. Therapy should be continuous.
By inhalation of powder, adults & children- 20mg 4 times daily, increased in severe cases to 8 times daily.
By inhalation of nebulised solution, adults & children- 20mg 4 times daily, increased in severe cases to 6 times daily.   </p>
        </div><!-- collapsible -->
        
      <div data-role="collapsible"> <!-- collapsible -->
          <h3>INTAL 5 Inhaler Sandi Aventis</h3>
          <p>Sodium cromoglycate 5mg/inhalation; 112 inhalations unit: spin inhaler.112 inhalations unit: 515.00 MRP</p>   
      </div><!-- collapsible -->

      <div data-role="collapsible"> <!-- collapsible -->
          <h3>NACROMIN Cozycap Square</h3>
          <p>Each Nacromin cozycap contains sodium cromoglycate BP 20mg. 'Cozycap' is a pre-metered single dose medication for inhalation, specially to be used with 'cozyhaler'.
Cozycap contains an admixture of micronised drug (less than 5m) with a carrier, lactose.
'Cozyhaler'- the dry powder inhalation (DPI) device, using cozycap, which is an effective and well accepted device for patients with asthma. The inhalation capsule delivers more drug to the lungs compared to nebulization of solution, but there is no difference in effectiveness. Cozyhalers are commercially available from Square Pharmaceuticals Ltd. <br><br>

<strong>Ind:</strong> Cozycap for inhalation is indicated for the preventive treatment of mild to moderate bronchial asthma, including the prevention of exercise-induced asthma. Sodium cromoglycate can prevent the asthmatic response to a variety of allergic and non-allergic stimuli. It is used in the management of chronic asthma for patients who connot be managed with inhaled b2-agonists alone; it is not used for acute attacks including acute severe asthma (status asthmaticus).
It is important that the regular administration of sodium cromoglycate is maintained both in the prophylactic control of asthma and in the management of other allergic conditions. Beneficial effects may take several weeks to become established. <br><br>

<strong>C/I; S/E; Precautions:</strong> See above under the text of sodium cromoglycate. <br><br>

<strong>Dosage & Admin:</strong> It should be administered by oral inhalation route with 'cozyhaler device'. Usual dose for adult and children over 5 years of age is 20mg (1 cozycap) 4 times daily, increased in severe cases to 8 times daily; additional doses may also be taken before exercise. Once the asthma has been stabilized it may be possible to reduce the dosage.
20mg cozycap x 30's pack: 99.90 MRP</p>   
</div><!-- collapsible -->


</div><!-- collapsible-set -->



<div data-role="collapsible-set" data-theme="a">

    <div data-role="collapsible"> <!-- collapsible -->
      <h3> NEDOCROMIL SODIUM: Aerosol Inhalation  </h3>
      <p> <strong>Ind:</strong> Prophylaxis of asthma; management of reversible obstructive airway diseases (ROAD) in patients of a wide age range. It is intended for regular prophylactic treatment and not for symptomatic relief. (Other than bronchial asthma, ROAD includes asthmatic bronchitis, late onset asthma, exercise induced asthma, and bronchospasm provoked by a variety of stimuli such as cold air, inhaled allergens, atmospheric pollutants and other irritants). <br><br>

<strong>C/I: Cautions: </strong>there are no specific contra- indications. Uses in pregnancy and lactating women- studies in pregnant and lactating animals have failed to reveal any hazard; however, as with all new medicines caution should be exercised, especially during the first trimester of pregnancy. <br><br>

<strong>S/E:</strong> see under sodium cromoglycate; also headache, nausea, vomiting, dyspepsia, abdominal pain (mild and transient); bitter taste. <br><br>

<strong>Dosage & Admin:</strong> adults (including the elderly) and children over 6 years of age, in initial and maintenance therapy 4mg (2 puffs) twice daily; if necessary may be increased to 4 times daily; when control achieved may be possible to reduce to 2 times daily. Regular use is
necessary.
Children below 6 years, not recommended.   </p>
    </div><!-- collapsible -->
      
    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TILADE Aerosol Inhaler Sandi Aventis</h3>
        <p>Nedocromil sodium 2mg/inhalation or puff; 112 inhalations unit: metered dose aerosol inhalation. It has a pharmacological action similar to that of sodium cromoglycate.Dose: See above.
    112 inhalations unit: 900.00 MRP</p>   
    </div><!-- collapsible -->


</div><!-- collapsible-set -->




<div data-role="collapsible-set" data-theme="b">

    <div data-role="collapsible"> <!-- collapsible -->
      <h3> KETOTIFEN: Tablet  </h3>
      <p> Ind: Prophylaxis of bronchial asthma; symptomatic relief of allergy such as hay fever, urticaria. <br><br>
C/I: Concurrent adin. of oral hypoglycaemics. S/E: Dry mouth, sedation. <br><br>
Cautions: Alertness may be impaired; avoid alcohol; previous anti-asthmatic treatment should be continued for a minimum of 2 weeks after initiation of ketotifen treatment.
Adult: 1-2 mg twice daily with food.
Child: Under 2 years, not recommended; over 2yrs. 1mg twice daily with food.   </p>
    </div><!-- collapsible -->
      


    <div data-role="collapsible"> <!-- collapsible -->
        <h3>AEROFEN Tab. Silva</h3>
        <p>Ketotifen fumerate 1mg/tablet. 50's pack: 75.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>AEROFEN Syp. Silva</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup.
    100ml bot: 35.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>ALARID Tab. Square</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>ALARID Syp. Square</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup.
    100ml bot: 40.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>BROKET Tab. Orion</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>BROKET Syp. Orion</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup.
    100ml bot: 40.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>FENAT Tab. Drug Inter.</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>FENAT Syp. Drug Inter.</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup.
    100ml bot: 36.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETIFEN Tab. Acme</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETIFEN Syp. Acme</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup.100m1 bot: 35.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETODIL Cap. Techno Drugs</h3>
        <p>Ketotifen fumerate 1mg/capsule.
    50's pack: 75.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOF Tab. Ibn Sina</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 152.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOF Syp. Ibn Sina</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100m1 bot: 35.40 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOMAR Tab. Incepta</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOMAR Syp. Incepta</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 40.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOTIF Tab. Delta</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KETOTIF Syp. Delta</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 35.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KOFEN Tab. Opsonin</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>KOFEN Syp. Opsonin</h3>
        <p>Ketotifen fumerate 1mg/5ml : syrup. 100m1 bot: 35.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>PROSMA Tab. ACI</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>PROSMA Syp. ACI</h3>
        <p>Ketotifen fumerate 1mg/5ml : syrup. 100ml bot: 40.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>STAFEN Tab. Aristopharma</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>STAFEN Syp. Aristopharma</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 35.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TIFEN Tab. Somatec</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TIFEN Syp. Somatec</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 37.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TOFEN Tab. Beximco</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TOFEN Syp. Beximco</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 40.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TOMA Syp. Navana</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 35.00 IP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TOTI Tab. SK+F</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>TOTI Syp. SK+F</h3>
        <p>Ketotifen fumerate 1mg/5ml: syrup. 100ml bot: 32.00 MRP</p>   
    </div><!-- collapsible -->

    <div data-role="collapsible"> <!-- collapsible -->
        <h3>ZADIT Syp. Popular</h3>
        <p>Ketotifen fumerate 1mg/tablet. 100's pack: 150.00 IP</p>   
    </div><!-- collapsible -->




</div><!-- collapsible-set -->


   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Leukotriene receptor antagonists" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Leukotriene receptor antagonists  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 


<div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> MONTELUKAST : Tablet </h3>
          <p>  Montelukast is a selective and orally active leukotriene receptor antagonist, synthesized chemically. It is used as prophylactic and also in the management of chronic asthma. <br><br>

<strong>Mode of action:</strong> Montelukast is a selective & competitive leukotriene receptor antagonist, that inhibits the cysteinyl leukotriene CysLT1 to occupy the receptors. The occupation of leukotriene receptors by the cysteinyl leukotriene (CysLT1) has been correlated with the pathophysiology of asthma. Montelukast demonstrates virtually no affinity for adrenergic, histamine, serotonin, muscarinic or prostanoid receptors.
Ind: Montelukast is indicated for the prophylaxis and treatment of chronic asthma in adults and paediatric patients 2 years of age and older. <br><br>

<strong>C/I:</strong> History of hypersensitivity to any component of the product. <br><br>

<strong>S/E:</strong> Montelukast is usually well-tolerated. However, there may be some side- effects, which include dizziness, headache, diarrhoea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.
Precautions: Montelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks (in case of status asthmaticus).
In rare cases, patients on therapy with Montelukast may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with churg-strauss syndrome- a condition which is often treated with systemic
corticosteroid therapy. Physician should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between Montelukast and these underlying conditions has not been established. <br><br>

<strong>Use in pregnancy & lactation:</strong> There are no adequate and well-controlled studies of Montelukast in pregnant women, so it should be used during pregnancy only if clearly needed. It is also not known whether Montelukast is excreted in human milk, so caution should be exercised when Montelukast is given to a nursing mother. <br><br>

<strong>Dosage & admin:</strong> Adults (15 years & over)- 10mg daily to be taken in the evening. Children, 6-14 years- 5mg daily to be taken in the evening; 2-5 years- 4mg daily to be taken in the evening. Paediatric patients younger than 2 years of age- not recommended. 
<br><br>

<strong>Drug Inter:</strong> Montelukast has been administered with other therapies routinely used in the prophylaxis and treatment of chronic asthma with no appropriate increase in adverse reactions. Cytochrome P-450 inducers: Although phenobarbital induces hepatic metabolism, no dosage adjustment for montelukast is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P-450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with montelukast.  </p>
        </div><!-- collapsible -->
        


<div data-role="collapsible"> <!-- collapsible -->
    <h3>AERON Tab. Healthcare</h3>
    <p>Montelukast sodium INN 10mg/tablet 10mg x 12's pack: 300.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LUMONA 4 Tab. SK+F</h3>
    <p>Montelukast sodium INN 5mg/tablet 4mg x 10's pack: 100.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LUMONA 10 Chew. Tab. SK+F</h3>
    <p>Montelukast sodium INN 10mg/tablet (chewable) 10mg x 10's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>M-KAST-5 Tab. Drug Inter.</h3>
    <p>Montelukast sodium INN 5mg/tablet 5mg x 30's pack: 300.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MOKAST Tab. Alco Pharma</h3>
    <p>Montelukast sodium INN 4mg & 10mg/tablet 4mg x 20's pack: 200.00 MRP 10mg x 10's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> 
<h3>MOLUS Tab. Apex</h3>
<p>Montelukast sodium INN 4mg & 10mg/tablet 4mg x 10's pack: 200.00 MRP
10mg x 10's pack: 350.00 MRP</p></div>

<div data-role="collapsible"> 
<h3>MONAS Tab. Acme</h3>
<p>Montelukast sodium INN 4mg, 5mg & 10mg/tablet
4mg x 5's pack: 35.00 MRP
5mg x 5's pack: 50.00 MRP
10mg x 5's pack: 100.00 MRP</p>
</div>

<div data-role="collapsible"> 
 <h3>MONOCAST Tab. Beximco</h3>
<p>Montelukast sodium INN 4mg, 5mg & 10mg/tablet
4mg x 20's pack: 140.00 IP
5mg x 20's pack: 200.00 IP
10mg x 10's pack: 200.00 IP</p>
</div>

<div data-role="collapsible"> 
 <h3>MONPROX Tab. Rangs Pharma </h3>
<p>Montelukast sodium INN 10mg/tablet
10mg x 10's pack: 200.00 MRP</p>
</div>

<div data-role="collapsible"> 
 <h3>MONTAIR Tab. Incepta</h3>
<p>Montelukast sodium INN 4mg, 5mg & 10mg/tablet
4mg x 30's pack: 210.00 MRP
5mg x 30's pack: 300.00 MRP
10mg x 20's pack: 400.00 MRP</p>
</div>

<div data-role="collapsible"> 
<h3> MONTENE Chew. Tab. Square</h3> 
<p>Montelukast sodium INN 4mg & 5mg/tablet (chewable)
4mg x 10's pack: 70.00 MRP
5mg x 10's pack: 100.00 MRP</p>
</div>

<div data-role="collapsible"> 
<h3>MONTENE 10 Tab. Square</h3> 
<p>Montelukast sodium INN 10mg/tablet
10mg x 10's pack: 200.00 MRP</p>
</div>

<div data-role="collapsible"> 
 <h3>ODMON Tab. Renata</h3> 
 <p>Montelukast sodium INN 5mg & 10mg/tablet 5mg x 10's pack: 150.00 MRP 10mg x 10's pack: 300.00 MRP</p>
</div>

<div data-role="collapsible"> 
 <h3>PROVAIR Chew. Tab. UniHealth</h3> 
 <p>Montelukast sodium INN 4mg & 5mg/tablet 4mg x 20's pack: 160.00 MRP
 5mg x 20's pack: 200.00 MRP</p>
</div>

<div data-role="collapsible"> 
<h3>PROVAIR 10 Tab. UniHealth</h3> 
<p>Montelukast sodium INN 10mg/tablet
10mg x 10's pack: 200.00 MRP</p>
</div>

<div data-role="collapsible"> 
 <h3>REVERSAIR Tab. ACI</h3>
<p>Montelukast sodium INN 10mg/tablet 10mg x 10's pack: 200.00 IP</p>
</div>



</div><!-- collapsible-set -->




<div data-role="collapsible-set" data-theme="a">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> ZAFIRLUKAST: Tablet  </h3>
          <p>  Zafirlukast is a leukotriene receptor antagonist, synthesized chemically. It is used as prophylactic and in the management of chronic asthma.  <br><br>

          <strong>Mode of action:</strong> Zafirlukast is a selective, competitive antagonist of cysteinyl leukotrienes (LTC4, LTD4 & LTE4) at the cysteinyl leukotriene receptor (currently designated as CysLT1). Zafirlukast demonstrates virtually no affinity for adrenergic, histamine, serotonin, muscarinic or prostanoid receptors. <br><br>

<strong>Ind:</strong> Zafirlukast is indicated for the prophylaxis and the management of chronic asthma in adults and children aged 12 years and over. <br><br>

<strong>C/I:</strong> History of hypersensitivity to the product or any of its ingredients; history of moderate or severe renal impairment; hepatic impairment or cirhosis. Zafirlukast is also contraindicated in children under 12 years of age until safety information is available. <br><br>

<strong>Adverse effects:</strong> Zafirlukast may be associated with headache or gastrointes-tinal disturbance, these symptoms are usually mild and do not necessitate withdrawal from therapy. Hypersensitivity reactions, including urticaria and angioedema have been reported; rashes, including blistering, have also been reported.
Infrequently, elevated serum transaminase levels have been observed, but rarely this transaminase profile has been consistent with drug-induced hepatitis which resolved following cessation of zafirlukast therapy. <br><br>

<strong>Warnings & Precautions:</strong> Zafirlukast should be taken regularly to achieve benefit, even during symptom free periods; zafirlukast therapy should normally be continued during acute exacerbations of asthma. Zafirlukast
does not allow a reduction in existing steroid treatment. As with inhaled steroids and cromones (disodium cromoglycate, nedocromil sodium), zafirlukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks.
Elderly- clinical experience with zafirlukast in the elderly (over 65 years) is limited and caution is recommended until furher information is available.
Renal impaiment- no dosage adjustment is necessary in patients with mild renal impairment. Zafirlukast has not been evaluated in the treatment of labile (brittle) or unstable asthma. Elevations in serum transaminases can occur during treatment with zafirlukast. These are usually asymp-tomatic and transient but could represent early evidence of hepatotoxicity.
If clinical symptoms or signs suggestive of liver dysfunction occur (e.g nausea, vomiting, right upper quadrant pain, fatigue, lethargy, flu-like symptoms, enlarged liver, pruritus and jaundice), the serum transaminases, in particular serum ALT, should be measured and the patient managed accordingly. A decision to discontinue zafirlukast should be individuailsed to the patient's conditon, weighing the risk of hepatic dysfunction against the clinical benefit of zafirlukast to the patient.  <br><br>

<strong>Pregnancy & Latation:</strong> The safety of zafirlukast in
human pregnancy has not been established, therefore, zafirlukast should be used during pregnancy only if clearly needed. Zafirlukast is excreted in human breast milk, so, zafirlukast should not be administered to mothers who are breast-feeding.
Dosage & Admin: Adults & children over 12 years of age- 20mg twice daily; it should be taken at least 1 hour before or 2 hours after meals, or as directed by the physician. <br><br>

<strong>Drug inter:</strong> Please see the manufacturer's literature.  </p>
        </div><!-- collapsible -->
  

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZAFIR Tab. Acme</h3>
    <p>Zafirlukast INN 20mg/tablet 20's pack: 400.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZAFNIL Tab. General</h3>
    <p>Zafirlukast INN 20mg/tablet 10's pack: 120.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZAFT Tab. Renata</h3>
    <p>Zafirlukast INN 20mg/tablet 10's pack: 260.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZALUKAST Tab. Alco Pharma</h3>
    <p>Zafirlukast INN 20mg/tablet 10's pack: 250.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ZUKAST Tab. Beximco</h3>
    <p>Zafirlukast INN 20mg/tablet 10's pack: 260.00 IP</p>   
</div><!-- collapsible -->



</div><!-- collapsible-set -->
   
    

    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Cough suppressants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Cough suppressants   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> DEXTROMETHORPHN HYDROBROMIDE: Syrup  </h3>
          <p> <strong>Ind:</strong> Non-narcotic antitussive agent, used in dry or painful cough. Benefits of treatment is only occasionally, such as if sleep is disturbed by a dry cough. <br><br>
<strong>C/I:</strong> Contra-indication or special
precaution in hepatic dysfunction <br><br>
<strong>S/E:</strong> Constipation; may occasionally cause drowsiness, excitation, dizziness, mental confusion & g.i. disturbances. Large doses may cause respiratory depression. <br><br>
<strong>Cautions:</strong> Asthma; as cough suppressant may cause sputum retention, this may be harmful in patients with ch. bronchitis & bronchiectasis. Though commonly used in acute bronchitis & pneumonia, they are usually unnecessary & such conditions are best treated by prompt administration of antibacterial drugs. <br><br>
<strong>Adult:</strong> 5m1 (1tsf) 3 or 4 times daily <br><br>
<strong>Child:</strong> Under 1 year, not recommended; 1- 5 years, 1/4 th adult dose; 6-12 years, 1/2 adult dose.
   </p>
        </div><!-- collapsible -->
  
<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROFEX Syp. Square</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100m1 bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COLDFLU Syp. Amico</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100m1 bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>D-COUGH Syp. Opsonin</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEPHAN Syp. Orion</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100m1 bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXOPHAN Syp. Somatec</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100ml bot: 24.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXSOL Syp. Gaco</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100m1 hot: 21.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXTROMETHORPHAN Syp. Beximco</h3>
    <p>Dextromethorphan 10mg/ 5ml: syrup.
100m1 bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXTROMETHORPHAN Elixir Ambee</h3>
    <p>Dextromethorphan 10mg/5ml: elixir 100m1 bot: 24.27 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EXOPHAN Syp. Apollo</h3>
    <p>Dextromethorphan 10mg/5ml: syrup.100ml bot: 24.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOMIPHEN Syp. Incepta</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100m1 bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TUSSIDEX Syp. UniHealth</h3>
    <p>Dextromethorphan 10mg/5ml: syrup. 100ml bot: 23.00 MRP</p>   
</div><!-- collapsible -->



      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Combined cough suppressants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Combined cough suppressants  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> Prescribing Notes  </h3>
          <p> <strong>DEXTROMETHORPHAN + PSEUDOEPHEDRINE + TRIPROLIDINE: Syrup
          Or, DEXTROMETHORPHAN +
          PSEUDOEPHEDRINE + GUAIPHENESIN: Syrup</strong>  <br><br>
This is a combination of dextromethorphan, an antitussive, pseudoephedrine, a decongestant and triprolidine, an antihistamine preparation.  <br><br>

<strong>Comp:</strong> Each 5m1 syrup contains dextromethorphan hydrobromide BP 10mg, pseudoephedrine hydrochloride BP 30mg and triprolidine hydrochloride BP 1.25mg or guaiphenesin BP 100mg <br><br>
<strong>Mode of action:</strong> Dextromethorphan is a cough suppressant, which has a central action on the cough centre in the medulla. Pseudoephedrine is an effective decongestant, which produces its decongestant effect in the upper respiratory tract. Triprolidine binds competitively with histamine H1 receptor and provides symptomatic relief of allergic rhinitis and common cold. <br><br>
<strong>Ind:</strong> Symptomatic relief of allergic rhinitis & upper resp. tract disorders accompanied by unproductive cough. <br><br>
<strong>C/I:</strong> Severe hypertension of severe coronary artery disease, MAOls therapy within the preceeding 2 wks. <br><br>
<strong>S/E:</strong> Dizziness, gastro-intestinal disturbances, fear, anxiety, restlessness, tremor, insomnia, confusion, irritability, sedation. 
<br><br>
<strong>Caution:</strong> Severe renal & hepatic impairment,
persistent cough. <br><br>
<strong>Dosage & admin:</strong> Adults & children over 12 years - 2 tsf 3 times daily.
Children 2-5 years - 1/2 tsf 3 times daily; 6-12 years 1 tsf 3 times daily.   </p>
        </div><!-- collapsible -->
  


<div data-role="collapsible"> <!-- collapsible -->
    <h3>A-COF Syp. Acme</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 38.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ANKOF Syp. General</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100m1 bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BENSIDYL Syp. Opsonin</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100m1 hot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFNO Syp. Alco Pharma</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXODEL Syp. Delta</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 60m1 bot: 35.00 MRP 100m1 bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DEXPOTEN Syp. SK+F</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100m1 bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DIXXAR Syp. ACI</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100m1 bot: 50.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KOFTEX-D Syp. Amico</h3>
    <p>Dextromethorphan hydrobromide 10mg, guaiphenesin BP 100mg & pseudoephedrine hydrochloride 30mg/ 5ml: syrup.
100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NILKOF Syp. Ambee</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>OFKOF Syp. Square</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>PRUDEX Syp. Beximco</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 38.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SUDOCOF Syp. Incepta</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml bot: 50.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TEXCO Syp. Globe</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100ml hot: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TUSSII)IN Syp. UniHealth</h3>
    <p>Dextromethorphan hydrobromide 10mg, pseudoephedrine hydrochloride 30mg & triprolidine hydrochloride 1.25mg/5ml: syrup. 100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Cough expectorants & mucolytics" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Cough expectorants & mucolytics   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<ul data-role="listview" data-inset="true" data-theme="b">        
     
       
        <li><a href="#AMBROXOL">AMBROXOL</a></li> 
        <li><a href="#BROMHEMNE">BROMHEMNE</a></li> 
        <li><a href="#CARBOCISTEINE">CARBOCISTEINE</a></li> 
        <li><a href="#GLYCEROL PREPN">GLYCEROL PREPN <br> 
        POTASSIUM GUAIACOL</a></li>
          
</ul>

   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->



<div data-role="page" id="AMBROXOL" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  AMBROXOL  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> AMBROXOL HCI: Drop/Syrup/Capsule  </h3>
          <p>  Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It is available as ambroxol hydrochloride BP 6mg/1ml drop, 15mg/5ml syrup and 75mg/capsule (sustained release). <br><br>

<strong>Mode of action:</strong> Ambroxol hydrochloride improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyper-reactivity. Ambroxol has anti-inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency. <br><br>

<strong>Ind:</strong> i. Productive cough. ii. Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis. iii. Laryngitis, pharyngitis, sinusitis and rhinitis associated with viscid mucus. iv. Asthmatic bronchitis, bronchial asthma with thick expectoration. v. Bronchiectasis. vi. Chronic pneumonia. <br><br>

<strong>C/I:</strong> Known hypersensitivity to ambroxol or bromhexine. <br><br>

<strong>S/E:</strong> Epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema has been reported. <br><br>

<strong>Precautions:</strong> Ambroxol should be given cautiously to patients with peptic ulceration or convulsive disorders. Caution should be taken in patients with hepatic and renal insufficiency. Pregnancy & lactation: Teratogenic and fetal toxicity studies have shown no harmful effect of ambroxol. However, it is advised not to use it in pregnancy, specially during the 1st trimester. Safety during lactation has not been established yet. <br><br>

<strong>Dosage & admin:</strong> Average daily dose
(preferably after meal).
Pediatric drops: 0-6 months old- 0.5m1 2 times ￼
a day; 6-12 months old- 1ml 2 times a day; 1-2 years old- 1.25m1 2 times a day.
Syrup preparation: 2-5 years old- 2.5 ml (1/2 tsf) 2-3 times a day; 5-10 years old- 5m1 (1 tsf) 2-3 times a day; 10 years old & adults- 10m1 (2 tsf) 3 times a day.
Tablet preparation (30mg): Adults and children over 10 years- 1 tablet (30mg) 3 times a day.
Capsule preparation (75mg SR): Adults and children over 12 years- 1 capsule once daily. Drug inter: Ambroxol should not be taken simultaneously with antitussives (e.g codeine) because phlegm, which has been liquefied by ambroxol might not be expectorated.  </p>
        </div><!-- collapsible -->
  

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACOREX Tab. Apex Ambroxol</h3>
    <p>hydrochloride BP 30mg/tablet
100's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACOREX Syp. Apex</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOLYT Syp. Incepta</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOLYT Drop Incepta</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOSIL Syp. Silva</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOSIL Drop Silva</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop.15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOTEN Syp. SK+F</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOTEN Drop SK+F</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBOXOL Syp. Kumudini</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBROSOL SR Cap. Popular</h3>
    <p>Ambroxol hydrochloride BP 75mg/capsule (sustained release) 30's pack: 150.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBROSOL Syp. Popular</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBROX 75 SR Cap. Square</h3>
    <p>Ambroxol hydrochloride BP 75mg/capsule (sustained release)
30's pack: 150.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBROX Syp. Square</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP </p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMBROX Drop Square</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AMSIV Syp. Delta</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROX Tab. Alco Pharma</h3>
    <p>Ambroxol hydrochloride BP 30mg/tablet 100's pack: 175.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROX Syp. Alco Pharma</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 28.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROX Syp. Navana</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROXIDIL Syp. Ziska</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DILYT Syp. Novo Healthcare</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FEMEX Syp. Globe</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KUFFLIN Syp. Desh</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LYTEX Syp. Ibn Sina</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LYTEX Drop Ibn Sina</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml hot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MBROXOL Syp. Benham</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOSOL Syp. Beximco</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOSOL Drop Beximco</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MYROX Syp. ACI</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MYROX Drop ACI</h3>
    <p>Ambroxol hydrochloride BP 6mg/ml: paediatric drop
15ml bot: 20.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>RIXOL Syp. Medicon</h3>
    <p>Ambroxol hydrochloride BP 15mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->



<div data-role="page" id="BROMHEMNE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> BROMHEMNE   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BROMHEXINE: Tablet/Syrup  </h3>
          <p> Bromhexine hydrochloride is a highly effective mucolytic expectorant syrup. It is used in the treatment of respiratory disorders associated with productive cough.
<strong>Mode of action:</strong> Bromhexine alters the structure of mucus to decrease its viscosity and therefore facilitate its removal by ciliary action or expectoration. <br><br>

<strong>Ind:</strong> Respiratory diseases associated with productive cough. <br><br>

<strong>C/I:</strong> Patients sensitive to bromhexine hydrochloride.  <br><br>

<strong>S/E:</strong> Gastrointestinal side-effects may occur occasionally with bromhexine and a transient rise in serum aminotransferase values has been reported. Other adverse effects may include- headache, dizziness, sweating and skin rash. Cautions: Since mucolytics may disrupt the gastric mucosa, so bromhexine should be used with care in patients with a history of peptic ulceration. Care is also advisable in asthmatic patients. <br><br>

<strong>Dosage & Admin: Adult:</strong> The recommended daily dose is 8-16mg (10-20m1) 3-4 times daily. Children: Suggested dosage for children aged 5-10 years, 4mg (5m1) 4 times daily; under 5 years, 4mg (5m1) twice daily.   </p>
        </div><!-- collapsible -->
  


<div data-role="collapsible"> <!-- collapsible -->
    <h3>A-COLD Syp. Acme</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLYT-4 Tab. Alco Pharma</h3>
    <p>Bromhexine hydrochloride BP 4mg/tablet. 50's pack: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLYT-8 Tab. Alco Pharma</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 50's pack: 50.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROLYT Syp. Alco Pharma</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100m1 bot: 27.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROMEX-8 Tab. Somatec</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet.
100's pack: 100.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROMEX Syp. Somatec Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100ml bot: 27.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROMOLIT Syp. Peoples</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BROXINE Syp. General</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml:syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COLD-B 4 Tab. Medimet</h3>
    <p>Bromhexine hydrochloride BP 4mg/tablet.
50's pack: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DE-COLD Syp. Aexim Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EXPECTO Syp. Aristopharma</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>HEMIN Syp. Bosco Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml:syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MEXILYT Syp. Pharmadesh</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 60ml bot: 18.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCARYL Syp. Marksman</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml hot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOF Tab. Salton</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet.
100's pack: 180.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOF Susp. Salton Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLA Syp. Amico Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml:syrup 100ml bot: 25.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLYT 8 Tab. Incepta</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 100's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLYT Syp. Incepta</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCONIL Syp. Ziska</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml:syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOPRONT Syp. Cosmic</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOSPEL 8 Tab. Square</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 100's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOSPEL Syp. Square</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCUT Syp. Bio-pharma</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 27.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MULYT-8 Tab. Gaco</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 100's pack: 149.73 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MULYT Syp. Gaco Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUNIL Syp. Opsonin Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100ml hot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUSOL 8 Tab. UniHealth</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 100's pack: 200.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUSOL Syp. UniHealth Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100m1 bot: 27.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUTE Syp. Proteety Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NAXCEL Syp. Kumudini</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>N-HEXIN Syp. Nipa Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>OMEXIN Syp. Delta Bromhexine</h3>
    <p>hydrochloride BP 4mg/5ml:syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SPULYT 8 Tab. Beximco</h3>
    <p>Bromhexine hydrochloride BP 8mg/tablet. 100's pack: 200.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SPULYT Syp. Beximco</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml:syrup 100ml bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>SPUTEN Syp. Silvah3</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml: syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOPSIL 4 Tab. Zenith</h3>
    <p>Bromhexine hydrochloride BP 4mg/tablet. 4mg x 100's pack 70.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TOPSIL Syp. Zenith</h3>
    <p>Bromhexine hydrochloride BP 4mg/5ml:syrup 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="CARBOCISTEINE" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> CARBOCISTEINE   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> CARBOCISTEINE: Capsule// Syrup  </h3>
          <p> Carbocisteine is a mucolytic expectorant preparation. <br><br>

<strong>Mode of action:</strong> It reduces the viscosity of non- infected secretions from mucus cells in the respiratory tract. The mucolytic action is due to two mechanisms. It breaks the disulphide bonds which cross-link certain glycoprotein molecules present in the mucus and also alters local ionic charges, both of which factors affect the viscosity of mucus. There is also evidence that it alters the composition of mucin secreted by the respiratory mucosa, decreasing the proportion of neutral glycopeptides and increasing the sialoglycopeptides. <br><br>

<strong>Ind:</strong> 1. Expectoration in the following diseases: upper respiratory tract inflammation (pharyngitis, laryngitis), acute bronchitis, bronchial asthma, chronic bronchitis, bronchiectasis, pulmonary tuberculosis. 2. Drainage in chronic sinusitis. 3. Drainage in otitis media (glue-ear) with effusion specially in children. <br><br>

<strong>C/I:</strong> Contraindicated in active peptic ulceration and in patients with hypersensitivity to the drug. S/E: Gastrointestinal discomfort, nausea, diarrhoea, gastrointestinal bleeding, headache and skin rash may occur.
Precautions: No specific precaution is recommended, but carbocisteine should be used with a caution in patients with a recent history of peptic ulcer and
recurrent gastrointestinal bleeding. <br><br>

<strong>Pregnancy & lactation:</strong> Although there are no reports of teratogenic effects with carbocisteine, the drug is not recommen-ded in the first trimester of pregnancy. No information available on the use of carbocisteine during lactation. <br><br>

<strong>Dosage & admin:</strong> Adults (includintg elderly): Dosage is based upon an initial dose of 2250mg daily in divided doses (750mg 3 times daily), reduced to 1500mg daily in divided doses (375mg 4 times daily), when a satisfactory response has been obtained. <br><br>

<strong>Children:</strong> Normal daily dose is 20mg/kg body weight in divided doses. The following dosage schedule is recommen-ded: 2-5 years, 62.5- 125mg 4 times daily; 6-12 years, 250mg 3 times daily.
Infants : Dosage in infants has not been established. <br><br>

<strong>Drug inter:</strong> Neither hazardous nor therapeutically significant interactions have been reported.   </p>
        </div><!-- collapsible -->
  

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CARBOLIN Cap. SK+F</h3>
    <p>Carbocisteine BP 375mg/capsule 30's pack: 75.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CARBOLIN Syp. SK+F</h3>
    <p>Carbocisteine BP 125mg/5ml: syrup
100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CARBOLIN DS Syp. SK+F</h3>
    <p>Carbocisteine BP 250mg/5ml: syrup (double strength)
100m1 bot: 40.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CARBOTEN DS Syp. Amico</h3>
    <p>Carbocisteine BP 250mg/5ml: syrup (double strength)
100ml bot: 40.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FLEGNIL Syp. Orion</h3>
    <p>Carbocisteine BP 125mg/5ml: syrup 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>FLEGNIL DS Syp. Orion</h3>
    <p>Carbocisteine BP 250mg/5ml: syrup
(double strength)
100ml bot: 40.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLEX Cap. General</h3>
    <p>Carbocisteine BP 375mg/capsule
30's pack: 75.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLEX Susp. General</h3>
    <p>Carbocisteine BP 125mg/5ml: suspension
100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>MUCOLEX DS Susp. General</h3>
    <p>Carbocisteine BP 250mg/5ml: syrup (double strength)
100m1 hot: 40.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NOKOF Cap. Beximco</h3>
    <p>Carbocisteine BP 375mg/capsule
30's pack: 75.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NOKOF Syp. Beximco</h3>
    <p>Carbocisteine BP 125mg/5ml: syrup
100m1 bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>NOKOF DS Syp. Beximco</h3>
    <p>Carbocisteine BP 250mg/5ml: syrup (double strength)
100ml bot: 40.00 IP</p>   
</div><!-- collapsible -->



      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="GLYCEROL PREPN" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  GLYCEROL PREPN <br> & POTASSIUM GUAIACOL </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 


<div data-role="collapsible-set" data-theme="a">

      <div data-role="collapsible"> <!-- collapsible -->
        <h3> HUNNY Oral SoIn. SK+F  </h3>
        <p> Hunny oral solution is a preparation containing
glycerol and liquid sucrose, used for relieving dry coughs and sore throats.
Mode of action: Glycerol acts by blocking sensory cough receptors within the respiratory tract. Glycerol also has demulcent properties (soothing effect). <br><br>

<strong>Ind:</strong> Hunny is indicated for relief of irritating, tickling dry coughs and sore throats. <br><br>

<strong>S/E:</strong> No side effect would be anticipated. Precaution: Diabetic patients should take note of the carbohydrate content of this product. Pregnancy & lactation: There is no sufficient data to establish the safety of the glycerol preparation in pregnancy and lactation. Nevertheless, glycerol or any other medication should be used during pregnancy or lactation only if clearly necessary.
 <br><br>

<strong>Dosage & admin:</strong> Oral administration only.  <br>

<strong>Adults & children over 5 years:</strong> 10m1 or 2 tsf; Children 1 to 5 years: 5m1 or 1 tsf; Children 3 months to 1 year: 5m1 or 1 tsf. The dose may be repeated 3-4 times a day. <br>

<strong>Elderly:</strong> No need for dosage reduction in the elderly. <br>

<strong>Overdose:</strong> Over dosage would not be expected to cause any problems and treatment would be merely symptomatic and supportive.<br><br>

<strong>Drug inter:</strong> No clinically significant interaction is known.
100ml bot: 30.00 IP   </p>
      </div><!-- collapsible -->
        
    

</div><!-- collapsible-set -->


<div data-role="collapsible-set" data-theme="b">

      <div data-role="collapsible"> <!-- collapsible -->
        <h3> POTASSIUM GUAIACOL  </h3>
        <p>  POTASSIUM GUAIACOL: Syrup <br><br>
<strong>Ind:</strong> Potassium guaiacol sulphonate is a stimulant cough expectorant. It liquifies thick viscid bronchial secretion & thereby facilitates its expulsion from the chest. It also helps in repair in chronic inflamma-tory conditions of the respiratory tract. 
<br><br> 

<strong>S/E:</strong> It produces mild irritation of the
bronchial mucous membrane during their excretion. <br><br>

<strong>Use & Dose:</strong> 1-2 tsf 2-4 times daily is the usual dosage.  </p>
      </div><!-- collapsible -->
        
      <div data-role="collapsible"> <!-- collapsible -->
          <h3>NPG Syp. Nipa</h3>
          <p>Potassium guaiacol sulphonate 125mg USP/5ml: syp
      100ml bot: 20.23 MRP</p>   
      </div><!-- collapsible -->

      <div data-role="collapsible"> <!-- collapsible -->
          <h3>POTASSIUM GUAIACOL Syp. Drug Inter.</h3>
          <p>Potassium guaiacol sulphonate 125mg USP/5ml: syrup.
      100m1 bot: 18.40 MRP</p>   
      </div><!-- collapsible -->


</div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->


<!-- /................page............................ -->



<div data-role="page" id="Combined cough expectorants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Combined cough expectorants  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> PSEUDOEPHEDRINE + GUAIPHENESIN + TRIPROLIDINE: Syrup  </h3>
          <p>  Ind: Cough expectorant & decongestant.
Dose: 2 tsf 3 to 4 times daily.
  </p>
        </div><!-- collapsible -->
  



<div data-role="collapsible"> <!-- collapsible -->
    <h3>ABEX Syp. Ibn Sina</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 30.38 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTIFED Syp. GlaxoSmithKline</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.34 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ACTIFEX Syp. Rasa</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>ANTUSS Syp. Gaco</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 35.40 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>AQUAPHEN Syp. Incepta</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 32.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BRUNEX Syp. Rephco</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>CODEX Syp. Ambee</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 40.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFDIL Syp. CPL</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFEX Syp. Skylab</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup.
60ml bot: 21.00 MRP
100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFNIL Syp. General</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFRID Syp. Acme</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COFSON Syp. Hudson</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COLDEX Syp. Millat</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COMBEX Syp. Hallmark</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COPEX Syp. Globe</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COPHILEX Syp. Opsonin</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5 ml: syrup. 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>COPHYL Syp. Pharmadesh</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5 ml: syrup. 100m1 bot: 31.50 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>DECOREX Syp. Reman</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 hot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>E-COF Syp. Edruc</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EFIN Syp. Syntho</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EXCOUGH Syp. Jalalabad</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EXODEL Syp. Delta</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5 ml: syrup. 60ml bot: 22.00 MRP
100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>EXPOTEN Syp. SK+F</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5 ml: syrup. 100m1 bot: 30.34 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>JEFRIL Syp. Jayson</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 28.32 IP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KEFOSED Syp. Cosmic</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KOFED Syp. Biopharma</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup.Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup.
100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>KOFTEX Syp. Amico</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>LUREX Syp. Chemico</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TUSSIN Syp. Orion</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml:
syrup.
100ml bot: 30.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TUSSY Syp. Somatec</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100ml bot: 35.00 MRP</p>   
</div><!-- collapsible -->

<div data-role="collapsible"> <!-- collapsible -->
    <h3>TYREX Syp. ACI</h3>
    <p>Pseudoephedrine BP 30mg, guaiphenesin BP 100mg & triprolidine BP 1.25mg/5ml: syrup. 100m1 bot: 35.00 MRP</p>   
</div><!-- collapsible -->


      </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Respiratory stimulants" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1> Respiratory stimulants   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

      <div data-role="collapsible-set" data-theme="b">

      <div data-role="collapsible"> <!-- collapsible -->
            <h3>ADRENALINE: Injection.</h3>
            <p>  Adrenaline 1mg in 1ml ampoule: injection <br><br>
            <strong>Ind:</strong> Bronchospasm, chronic bronchitis; emergency treatment of acute anaphylaxis. <br><br>
            <strong>C/I; S/E; Cautions:</strong> See under bronchodilators Dose: 1 amp. (1m1) to be injected s.c, i.m, i.v or direct intracardiac injection. May be repeated, if necessary. <br><br>
            <strong>Prepns:</strong> See under bronchodilators  </p>
      </div><!-- collapsible -->

      </div><!-- collapsible-set -->

            <div data-role="collapsible-set" data-theme="a">

                <div data-role="collapsible"> <!-- collapsible -->
                <h3> AMINOPHYLLINE: Injection.  </h3>
                <p>  Aminophylline 250mg in 10ml ampoule for slow i.v injection. <br><br>
                <strong>Ind:</strong> It is indicated for the treatment and prophylaxis of bronchospasm associated with asthma, emphysema and chronic bronchitis. Also indicated in adults for the treatment of cardiac asthma and left ventricular or congestive cardiac failure. <br><br>
                <strong>Caution:</strong> Rapid injection may result in cardiac arrest. <br><br>
                <strong>Dosage:</strong> 250-500mg given over 10-15 mins. Prepns: See under Bronchodilators.  </p>
                </div><!-- collapsible -->

            </div><!-- collapsible-set -->

                    <div data-role="collapsible-set" data-theme="b">

                        <div data-role="collapsible"> <!-- collapsible -->
                            <h3> NIKETHAMIDE Inj. Jayson  </h3>
                            <p>Nikethamide 25% injection in 2ml ampoule: injection <br><br>
                            <strong>Ind:</strong> Acute respiratory failure <br><br>
                            <strong>C/I:</strong> Respiratory failure due to neurological disease or drug overdose. <br><br>
                            <strong>S/E:</strong> Vomiting, restlessness, convulsions. Dosage & admin: 2 to 10m1 by slow i.v injection of the usual 25% solution every 20 to 30 mins. if necessary.
                            10 amps pack: 40.00 IP</p>
                        </div><!-- collapsible -->

                    </div><!-- collapsible-set -->

                              <div data-role="collapsible-set" data-theme="a">

                                      <div data-role="collapsible"> <!-- collapsible -->
                                      <h3> Morphine & other narcotic analgesic antagonists  </h3>
                                      <p>  NALOXONE: Injection <br>
                                      Naloxone hydrochloride is a respiratory stimulant, which antagonises the respiratory depression action of morphine & other narcotic analgesics. Ind: Reversal of narcotic-induced respiratory depression, including that due to pentazocine & dextropropoxyphen. Overdosage with morphine like compounds. Diagnosis of acute opioid overdosage. <br><br>

                                      <strong>Caution:</strong> Pregnancy (except in labour); opioid dependence. Keep patient under observation as repeat doses may be needed. <br><br>

                                      <strong>Dosage & admin:</strong>
                                      Adult: 0.4-2mg by i.v, i. m, or s.c inj. every 2-3 min. as required or by i.v infusion to a maximum of 10mg if respiratory function does not improve. By continuous i.v. infusion, 2mg diluted in 500m1 i.v. infusion solution at a rate adjusted according to the response. Post operative- 0.1-0.2mg i.v. repeated as required. Child: Neonates, see below; Others, 10mcg/ Kg by i.v., i.m. or s.c. inj. repeated as reqd. or by i.v. infusion  </p>
                                </div><!-- collapsible -->

                                    <div data-role="collapsible"> <!-- collapsible -->
                                    <h3>NALOXONE Inj. DBL/Globex</h3>
                                    <p>Naloxone hydrochloride 400mcg (0.4mg)/1ml ampoule: injection
                                    1ml amp: 180.10 MRP</p>   
                                    </div><!-- collapsible -->
  

                              </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->



<!-- /................page............................ -->



<div data-role="page" id="Aromatic inhalations" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  Aromatic inhalations   </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<p> Aromatic inhalations: inhalations containing volatile substances such as benzoin tincture, menthol, eucalyptus oil- known as aromatic inhalations, are traditionally used in respiratory discomfort as in bronchitis for deliberate inspiration & also used for the relief of nasal obstruction in acute rhinitis or sinusitis.   </p>

      <div data-role="collapsible-set" data-theme="b">

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BENZOIN TINCTURE: Inhalation  </h3>
          <p> Benzoin tincture containing balsamic acids
approx. 4.5% BP: volatile compound. <br><br>
Ind: respiratory discomfort as in bronchitis, nasal congestion in acute rhinitis or sinusitis.
Dosage & admin: Add one teaspoonful to a pint of hot, (not boiling), water and inhale the
vapour. <br><br>
Children- the use of strong aromatic
decongestants is not advised for infants under the age of 3 months.   </p>
        </div><!-- collapsible -->
  

<div data-role="collapsible"> <!-- collapsible -->
    <h3>BENZOIN Tinct. Jayson</h3>
    <p>Benzoin tincture containing balsamic acids approx. 4.5% BP: volatile compound for inhalation.
450m1 container: 240.46 IP</p>   
</div><!-- collapsible -->
      </div><!-- collapsible-set -->


  <div data-role="collapsible-set" data-theme="b">
      <div data-role="collapsible"> <!-- collapsible -->
          <h3>MENTHOL & EUCALYPTUS OIL: Inhalation</h3>
          <p>Racementhol or levomenthol 2gm, eucalyptus oil 10ml, light magnesium carbonate 7gm, water to 100ml: inhalation 
          <br><br>
Ind: Respiratory discomfort as in bronchitis, nasal congestion in acute rhinitis or sinusitis. <br><br>
Use: add one teaspoonful to a pint of hot, (not boiling), water and inhale the vapour. Children- the use of strong aromatic decongestants is not advised for infants under
the age of 3 months.
Preparations: Available in the market.</p>   
      </div><!-- collapsible -->
  </div><!-- collapsible-set -->
   
    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->

<!-- /................page............................ -->


<div data-role="page" id="centrally acting antihypertensive drugs" data-theme="a"> <!-- /page snippet -->
 
   <div data-role="header"> <!-- /header -->
      <h1>  RESPIRATORY GLUCOCORTICOIDS: CORTICOSTEROIDS  </h1>
      <a  rel="external" href ="Index.html" data-transition="flip" title="home">Home</a>
      <a  rel="external" href ="search.html" data-transition="flip" title="search">search</a>
   </div>  <!-- /header -->


<!-- content -->
  <div data-theme="b"
    data-role="content"> 

<p> Glucocorticoid steroid preparations are found effective in asthma; they reduce bronchial mucosal inflammation by reducing oedema & secretion of mucus into the airway. Chronic obstructive pulmonary diseases usually show little or no response to corticosteroids. Whether inhaled corticosteroids improve the lung function in COPD yet not been established; but, corticosteroid inhalations are recommended for prophylactic treatment of asthma when patients are using a beta2-stimulant (agonist) 3 times a week or more or if symptoms disturb sleep more than once a week or if the patient has suffered exacerbations in the last 2 years requiring a systemic corticosteroid or a nebulised bronchodilator.21 Commonly used respiratory corticosteroids are- Beclomethasone dipropionate, Budesonide, Ciclesonide, Fluticasone propionate, Mometasone furoate, Triamcinolone etc.

<strong>Mode of action:</strong> The precise mechanism of glucocorticoid action in asthma is unknown. Glucocorticoids have been shown to inhibit multiple cell types (e.g mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils) and mediator production and secretion (e.g histamine, eicosanoids, leukotrienes, and cytokines) involved in the asthmatic response. These anti-inflammatory actions of glucocorticoids may contribute to their efficacy in asthma. <br><br>

<strong>Ind; C/I:</strong> See below under the individual preparation. <br><br>

<strong>S/E:</strong> Inhaled corticosteroids have considerably fewer systemic side-effects than oral corticosteroids, but high-dose inhalations are sometimes associated with some adrenal suppression and effects on bone metabolism; also hoarseness of voice and candidiasis of mouth or throat (usually only with large doses); rearly rash, Precautions: Active or quiescent tuberculosis; may need to reinstate systemic therapy during periods of stress or when airways obstruction or mucus prevent drug access to smaller airways. During withdrawal from oral corticosteroids, some patients may experience symptoms of systemically active corticosteroid withdrawal, e.g joint and/or muscular pain, lassitude and depression, despite maintenance or even improvement of respiratory functions. If there is paradoxical bronchospasm, steroid inhalation should be discontinued and alternative therapy should be given; or, transfer from an aerosol inhalation to a dry powder inhalation.
Because of the possibility of systemic absorption of inhaled corticosteroids, patients treated with these drugs should be observed carefully for any evidence of systemic corticosteroid effets. Particular care should be taken in observing patients post operatively or during periods of stress for evidence of inadequate adrenal respone. 

<strong>Dosage & admin:</strong> See below under the individul preparation.</p>


<a href="#" data-role="button" data-theme="a"> </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> BECLOMETHASONE DIPROPIONATE: Inhaler (DPI/MDI) </h3>
          <p> Beclomethasone dipropionate is a commonly used synthetic halogenated respiratory corticosteroid with potent anti-inflammatory activity. It is available as dry powder inhaler (DPI) & metered dose aerosol inhaler (MDI). <br>

<strong>Inhaler (DPI):</strong> Beclomethasone dipropionate, available as 100mcg, 200mcg, & 400mcg/capsule (cyclocap): Dry powder inhaler (DPI), for oral inhalation only. <br>
<strong>Inhaler (MDI):</strong> Beclomethasone dipropionate, available as 50mcg, 100mcg, & 250mcg/puff or actuation: Metered dose inhaler (MDI), using CFC (chlorofluorocarbon) as propellant. Inhaler HFA (MDI): Beclomethasone dipropionate, available as 50mcg & 100mcg/puff or actuation: Metered dose inhaler (MDI), using HFA (hydrofluoroalkane) as propellant.
CFC (Chlorofluorocarbon): CFC- using as MDI propellant is safe for human, but, as it emits CFC to the environment, it harms the planet by depleting ozone layer.
HFA (Hydrofluoroalkane): Recently an advanced HFA (Hydrofluoroalkane) technology has developed as MDI propellant replacing CFC propellant. HFA is an ozone-benign, environment friendly, CFC-free MDI propellant. <br><br>

<strong>Mode of action:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Ind:</strong> Prophylaxis and maintenance treatment of asthma specially if not fully controlled by bronchodilators or cromoglycate.

<strong>S/E; Cautions:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Dosage & admin:</strong>

<strong>By inhalation (DPI):</strong> Adults & adolescents: Recommended starting dose is 200mcg twice daily or 100mcg 3-4 times daily; in more severe cases initially 600-800mcg may be given daily. Children (5-11 years): 50-100mcg 2-4 times daily.
Dry powder inhaler (DPI) is administered by a device (such as Cozyhaler, Cyclohaler, Rotahaler) through oral inhalation route only. Rinsing the mouth after inhalation is advised. <br><br>

<strong>By inhalation (MDI):</strong> Adults & adolescents: Recommended starting dose- 500mcg (250mcg/puff) twice daily or 250mcg (250mcg/puff) four times daily; if necessary may be increased to 500mcg (250mcg/puff) 3-4 times daily in severe condition. High doses upto 2000mcg in a day may control asthmatics not adequately controlled with more conventional doses. The usual recommended maintenance dose is 100-250mcg given 3 or 4 times a day. Or, alternatively 200-500mcg given twice daily has been found effective in some patients. Children (5-11 years): The usual starting dose is 100mcg twice daily. Some patients may require 100mcg 3 to 4 times daily or 200mcg twice daily. Total dose for children should not exceed 500mcg daily.
By inhalation HFA (MDI): The recommended dosage of HFA based inhalation aerosol relative to traditional CFC based inhalation is lower due to differences in delivery characteristics between the products. <br><br>

<strong>Adults & adolescents:</strong> Recommended starting dosage- in patients previously treated with bronchodilators alone, is 50-100mcg twice daily, may be increased upto 400mcg twice daily; dosage in patients previously treated with inhaled corticosteroid, is 50-200mcg twice daily, may be increased upto 400mcg twice daily.
Children (5-11 years): Recommended starting dosage- in patients previously treated with bronchodilators alone, is 50-100mcg twice daily, may be increased and maintained upto 100mcg twice daily; dosage in patients previously treated with inhaled corticosteroid, is 50-200mcg twice daily, may be maintained upto 100mcg twice daily.   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> ASCON Inhaler (MDI) Acme </h3>
          <p> Ascon 100: Beclomethasone dipropionate 100mcg/ puff or actuation: metered dose inhaler (MDI).
Ascon 250: Beclomethasone dipropionate 250mcg/puff or actuation: metered dose inhaler (MDI). <br><br>
<strong>Ind:</strong> Bronchial asthma <br><br>
<strong>Dosage & admin:</strong> See above under the text (Dosage of inhaler MDI).
Ascon 100 x 200 doses unit: 200.00 MRP
Ascon 250 x 200 doses unit: 250.00 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BECLOD Inhaler (DPI) Acme  </h3>
          <p> Beclod-100: Beclomethasone dipropionate 100mcg/capsule (Rotacap): dry powder inhalation (DPI). Beclod-200: Beclomethasone dipropionate 200mcg/capsule (Rotacap): dry powder inhalation (DPI).
Rotacap contains single dose dry powder for oral inhalation, specially to be used with 'Rotahaler'. Ind: Bronchial asthma
Dosage & admin: See above under the text (Dosage of inhaler DPI).
Beclod 100 x 30 doses (rotacap): 45.00 MRP Beclod 200 x 30 doses (rotacap): 63.60 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BECLOMIN Inhaler (MDI) Square  </h3>
          <p> Beclomin 100: Beclomethasone dipropionate 100mcg/ puff or actuation: metered dose inhaler (MDI).
Beclomin 250: Beclomethasone dipropionate 250mcg/puff or actuation: metered dose inhaler (MDI).
Ind: Bronchial asthma
Dosage & admin: See above under the text (Dosage of inhaler MDI).
100mcg x 200 doses unit: 200.00 MRP 250mcg x 200 doses unit: 250.00 MRP   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>  CYCLOSON Inhaler (DPI) Pharmachemie/ City Overseas </h3>
          <p>  Cycloson 100: Beclomethasone dipropionate 100mcg/capsule (cyclocap): dry powder inhalation (DPI).
Cycloson 200: Beclomethasone dipropionate 200mcg/capsule (cyclocap): dry powder inhalation (DPI).
Cycloson 400: Beclomethasone dipropionate 400mcg/capsule (cyclocap): dry powder inhalation (DPI).
Cyclocap contains single dose dry powder for oral inhalation, specially to be used with 'Cyclohaler'. Ind: Bronchial asthma  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> Dosage & admin: See above under the text (Dosage of inhaler DPI).  </h3>
          <p>  100mcg x 100 cyclocaps pack: 155.00 TP 200mcg x 100 cyclocaps pack: 160.00 TP 400mcg x 100 cyclocaps pack: 170.00 TP Price of Cyclohaler (1's): 125.00 TP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>  DECOMIT Inhaler (MDI) Beximco </h3>
          <p> Decomit 100: Beclomethasone dipropionate 100mcg/ puff or actuation: metered dose inhaler. Decomit 250: Beclomethasone dipropionate 250mcg/puff or actuation: metered dose inhaler. Ind: Bronchial asthma.
Dosage & admin: See above under the text (Dosage of inhaler MDI).
Decomit 100 x 200 doses unit: 200.00 IP
Decomit 250 x 200 doses unit: 250.00 IP   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> DECOMIT HFA Inhaler (MDI) Beximco  </h3>
          <p> Decomit 50 HFA: Beclomethasone dipropionate 50mcg/puff or actuation: metered dose inhaler (MDI), using HFA (hydrofluoroalkane) as propellant.
Decomit 100 HFA: Beclomethasone dipropionate 100mcg/puff or actuation: metered dose inhaler (MDI), using HFA (hydrofluoroalkane) as propellant.
Ind: Bronchial asthma.
Dosage & admin: See above under the text (Dosage of inhaler HFA (MDI)).
Decomit 50 HFA x 200 doses unit: 220.00 IP Decomit 100 HFA x 200 doses unit: 270.00 IP   </p>
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->
   

<a href="#" data-role="button" data-theme="a"> </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> BUDESONIDE: Inhaler  </h3>
          <p>  Budesonide is a respiratory corticosteroid, used as inhaler, recommended mainly for prophylactic treatment of asthma. <br><br>

<strong>Mode of action:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Ind:</strong> Budesonide inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. It is also indicated for patients requiring oral corticosteroid therapy for asthma. It is not indicated for the relief of acute bronchospasm. <br><br>

<strong>C/I:</strong> Budesonide is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
Hypersensitivity to any of the ingredients of this preparation contraindicates its use. <br><br>

<strong>S/E; Cautions:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Pregnancy & lactation:</strong> There are no adequate and well-controlled studies with the drug in pregnant women. The drug should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. As corticosteroids are secreted in human milk, and potential for adverse reactions in nursing infants from any corticosteroid, a decision should be made whether to discontinue nursing or to discontinue the drug taking into account the importance of the drug to the mother. But, actual data for budesonide are yet lacking. <br><br>

<strong>Dosage & admin:</strong> The recommended starting dose and the highest recommended dose of this drug, based on prior asthma therapy, are given as below: <br>
Adults & Adolescents: <br>
Patient treated previously with bronchodilators alone- recommended starting dose is 200- 400mcg twice daily; highest recommended dose is 400mcg twice daily. <br>
Patient treated previously with inhaled corticosteroids- recommended starting dose is 200-400mcg twice daily; highest recommended dose is 800mcg twice daily. <br>
Patient treated previously with oral corticosteroids- recommended starting dose is 400-800mcg twice daily; highest recommended dose is 800mcg twice daily.
Children 6 to 11 Years: <br>
Patient treated previously with bronchodilators alone- recommended starting dose is 200mcg twice daily; highest recommended dose is 400mcg twice daily. <br>
Patient treated previously with inhaled corticosteroids- recommended starting dose is 200mcg twice daily; highest recommended dose is 400mcg twice daily. <br>
In patients with mild to moderate asthma who are well-controlled on inhaled corticosteroids, dosing with the drug 200mcg or 400mcg may be considered. This can be administered once daily either in the morning or in the evening. Rinsing the mouth after each inhalation is advised. <br>

<strong>Drug inter:</strong> In clinical studies, concurrent administration of budesonide and other drugs commonly used in the treatment of asthma has not resulted in an increased frequency of adverse effects. Ketoconazole, a potent inhibitor of cytochrome p450 3A, may increase plasma levels of budesonide during concomitant dosing. The clinical signifcance of concomitant administration of ketoconazole with this drug is not known, but caution may be warranted.  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> AERONID Inhaler (MDI) Beximco </h3>
          <p>  Budesonide BP 200mcg per metered dose or actuation (puff): metered-dose aerosol inhalation (MDI).
Dosage & admin: See above under the text of Budesonide.
Aeronid inhaler is administered by a metered-dose aerosol inhalation (MDI) device.
200mcg x 120 doses (puffs): 400.00 IP </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BUDESON-200 Inhaler (DPI) Acme  </h3>
          <p>  Budesonide BP 200mcg/Rotacap: dry powder inhalation (DPI).
Budeson inhaler is a DPI (dry powder inhalation) system and administered by Rotahaler device through oral inhalation route.
Rotahaler, a dry powder inhalation (DPI) device. Dosage & admin: See above under the text of Budesonide.
Budeson inhaler
is administered by Rotahaler through oral inhalation route.
Rinsing the mouth after inhalation is advised. 200mcg x 30 doses (puffs): 75.00 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> CYCORTIDE Inhalar (DPI) Pharmachemie, B.V/ City Overseas  </h3>
          <p>  Budesonide 200mcg & 400mcg/capsule
(cyclocap): dry powder inhalation (DPI)
Cyclocap contains single dose dry powder for oral inhalation, specially to be used with 'cyclohaler'. Cyclohaler, a dry powder inhalation (DPI) device, using cyclocap.
Dosage & admin: See above under the text of Budesonide.
Cycortide cyclocap is administered by cyclohaler through oral inhalation route.
Rinsing the mouth after inhalation is advised. 200mcg x 100 cyclocaps pack: 185.00 TP 400mcg x 100 cyclocaps pack: 230.00 TP Price of Cyclohaler (Ps): 125.00 TP  </p>
        </div><!-- collapsible -->   
      </div><!-- collapsible-set -->   


<a href="#" data-role="button" data-theme="a"> </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> CICLESONIDE </h3>
          <p>  Ciclesonide is a new generation inhaled corticosteroid for asthma control. It is available as metered dose inhalation (MDI) aerosol, in two strengths- 80mcg/actuation or dose & 160mcg/actuation or dose. Each canister contains 120 metered doses for both concentrations. <br><br>

<strong>Mode of action:</strong> Ciclesonide is an ester prodrug, which is hydrolysed by endogenous esterases in the lung to form its active metabolite. The activated ciclesonide has an approximately 100- fold greater affinity for glucocorticoid receptors compared with the parent compound. <br><br>

<strong>Ind:</strong> For the treatment to control persistent asthma in adults (18 years and older). <br><br>

<strong>C/I:</strong> Patients with known hypersensitivity to any of the ingredients of the product. <br><br>

<strong>S/E; Cautions:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Pregnancy & lactation:</strong> If the potential benefit to the mother justifies the potential risk to the mother, foetus or child, the lowest effective dose
of ciclesonide needed to maintain adequate
asthma control should be used. <br><br>

<strong>Dosage & admin:</strong> Starting dose of ciclesonide is 160mcg once daily, which is usual and also the maximum dose. Dose reduction to 80mcg once daily may be an effective maintenance dose for some patients. Ciclesonide should preferably be administered in the evening. Although morning dosing of ciclesonide has also been shown to be effective. <br><br>

<strong>Drug inter:</strong> Co-administration with a potent inhibitor of the cytochrome P450 3A4 system (e.g ketoconazole, itraconazole and ritonavir or nelfinavir) should be considered with caution. The risk of clinical adverse effect (e.g cushingoid syndrome) cannot be excluded. <br><br>

<strong>Storage:</strong> The inhaler should be stored below 30°C, protected from direct sunlight and heat. The canister should not be broken, punctured or burnt, even when apparently empty. Keep away from eyes.  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>CESONIDE 80 Inhaler (MDI) Beximco  </h3>
          <p>  Ciclesonide 80mcg/actuation or metered dose (or puff): metered dose aerosol inhalation (MDI). Dosage & admin: See above under the text of ciclesonide.
80mcg x 120 doses unit: 250.00 IP </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>  CESONIDE 160 Inhaler (MDI) Beximco </h3>
          <p> Ciclesonide 160mcg/actuation or metered dose (or puff): metered dose aerosol inhalation (MDI). Dosage & admin: See above under the text of ciclesonide.
160mcg x 120 doses unit: 350.00 IP   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>EZONIDE 80 Inhaler Square   </h3>
          <p> Ciclesonide 80mcg/actuation or metered dose (or puff): metered dose aerosol inhalation (MDI). Dosage & admin: See above under the text of ciclesonide.
80mcg x 120 doses unit: 250.00 MRP   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> EZONIDE 160 Inhaler Square  </h3>
          <p>  Ciclesonide 160mcg/actuation or metered dose (or puff): metered dose aerosol inhalation (MDI). Dosage & admin: See above under the text of ciclesonide.
          160mcg x 120 doses unit: 350.00 MRP  </p>
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->



<a href="#" data-role="button" data-theme="a"> </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> FLUTICASONE PROPIONATE: Inhaler  </h3>
          <p> <strong>Ind:</strong> Fluticasone propionate is indicated for the maintenance treatment of asthma and prophylactic therapy in patients 4 years of age and older. It is not indicated for the relief of acute bronchospasm. C/I: Fluticasone propionate is contraindicated in patients with a history of hypersensitivity to any of its components. It is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
Patients requiring oral corticosteroids should be
weaned slowly from systemic corticosteroid use after transferring to fluticasone propionate inhalation.
Fluticasone propionate inhalation is not to be regarded as a bronchodilator and is not indicated for rapid relief of broncho-spasm.
 <br><br>

<strong>S/E; Cautions:</strong> See above under the text of respiratory corticosteroids. <br><br>

<strong>Pregnancy & lactation:</strong> Administration of fluticasone propionate during pregnancy & lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus. <br><br>

<strong>Geriatric use:</strong> In geriatric patients (65 years of age or older) treated with fluticasone propionate inhalation, efficacy and safety did not differ from that in younger patients. Consequently, no dosage adjustment is recommended. <br><br>

<strong>Dosage & admin:</strong>
The recommended starting dose and the highest recommended dose of fluticasone propionate inhalation, based on prior anti- asthma therapy, are as following: <br>

<strong>Adults & adolescents:</strong> Along with bronchodilators- starting dose 100mcg twice daily, highest dose 500mcg twice daily. Inhaled corticosteroids- starting dose 100- 250mcg twice daily, highest dose 500mcg twice daily.
Oral corticosterolds- starting dose 1000mcg twice daily, highest dose 1000mcg twice daily. Children 4 to 11 years: Along with bronchodilators- starting dose 50mcg twice daily, highest dose 100mcg twice daily.
Inhaled corticosteroids- starting dose 50mcg twice daily, highest dose 100mcg twice daily. Individual patients will experience a variable time to onset and degree of symptom relief. Generally, fluticasone propionate inhalation has a relatively rapid onset of action for an inhaled corticosteroid. Improvement in asthma control following inhaled administration of fluticasone propionate can occur within 24 hours of beginning the treatment, although maximum benefit may not be achieved for 1 to 2 weeks or longer after starting the treatment. After asthma stability has been achieved, it is always desirable to titrate to the lowest effective dose to reduce the possibility of side effects. Doses as low as 50mcg twice daily have been shown to be effective in some patients. For patients who do not respond adequately to the starting dose after 2 weeks of therapy, higher doses may provide additional asthma control. The safety and efficacy of excess administration has not been established.
   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> FLUTICON Inhaler (DPI) Acme  </h3>
          <p> Fluticon-50 inhaler: Fluticasone propionate BP 50mcg/Rotacap: dry powder inhalation (DPI). Fluticon-100 inhaler: Fluticasone propionate BP 100mcg/Rotacap: dry powder inhalation (DPI). Fluticon-250 inhaler: Fluticasone propionate BP 250mcg/Rotacap: dry powder inhalation (DPI). Fluticon-500 inhaler: Fluticasone propionate BP 500mcg/Rotacap: dry powder inhalation (DPI). Fluticon inhaler is a DPI (dry powder inhalation) system and administered by Rotahaler device through oral inhalation route.Rotahaler, a dry powder inhalation (DPI) device. <br><br>

<strong>Dosage & admin:</strong> See above under the text of fluticasone propionate.
'Fluticon inhaler' is administered by Rotahaler through oral inhalation route in patients 4 years of age and older.
Rinsing the mouth after inhalation is advised.
Fluticon-50 x 30 doses (puffs): 75.00 MRP Fluticon-100 x 30 doses (puffs): 127.50 MRP Fluticon-250 x 30 doses (puffs): 240.00 MRP Fluticon-500 x 30 doses (puffs): 390.00 MRP   </p>
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->



<a href="#" data-role="button" data-theme="a">TRIAMCINOLONE ACETONIDE </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> AZMACORT Oral Inhaler Sanofi Aventis  </h3>
          <p>   Triamcinolone acetonide 200mcg/ actuation (of which approximately 100mcg are delivered from the unit in-vitro testing); 240 inhalations-unit : oral inhaler <br><br>

<strong>Ind:</strong> Triamcinolone oral inhaler is indicated only for patients who require chronic treatment with corticosteroids for the control of the symptoms of bronchial astham. Such patients would include those
already receiving systemic corticosteroids and selected patients who are inadequately controlled on a non-steroid regimen and in whom steroid therapy has been withheld because of concern over potential adverse effects. Triamcinolone oral inhaler is not indicated: i. for relief of asthma which can be controlled by bronchodilators and other non-steroid medications; ii. in patients who require systemic corticosteroid treatment infrequently; iii. in the treatment of non- asthmatic bronchitis. <br><br>

<strong>C/I:</strong> It is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to any of the ingredients of this preparation. Localized infections with candida albicans have occurred infrequently in the mouth and pharynx. <br><br>

<strong>S/E; Cautions; Warnings:</strong> See above under beclomethasone aerosol inhaler. <br><br>

<strong>Dosage & Admin:</strong> All patients should be instructed that the Triamcinolone oral inhaler must be used on a regular daily basis. Reliable dosage delivery can not be assured after 240 actuations and patients should be cautioned against longer use of individual canisters. Good oral hygiene including rinsing of the mouth after inhalation is recommended. <br><br>

<strong>Adults</strong>- the usual dosage is 2 inhalations (approximately 200mcg) given 3 to 4 times a day. The maximal daily intake should not exceed 16 inhalations (1600mcg) in adults. Higher initial doses (12 to 16 inhalations per day) may be advisable in patients with more asthma, the dosage then being adjusted down- ward according to the response of the patient. In some patients maintenance can be accomplished when the total daily dose is given on a twice a day schedule. <br><br>

<strong>Children</strong>- 6 to 12 years of age, the usual dosage is 1 or 2 inhalations (100mcg or 200mcg) given 3 to 4 times a day according to the response of the patient.
The maximal daily intake should not exceed 12 inhalations (1200mcg) in children of 6-12 years. Insufficient clinical data exist with respect to the administration of triamcinolone oral inhaler in children below the age of 6 years. The long-term effects of inhaled steroids on growth are still under evaluation.
Patients receiving bronchodilators by inhalation should be advised to use the bronchodilator before triamcinolone oral inhaler in order to enhance penetration of the drug into the bronchial tree. After use of an aerosol bronchodilator, several minutes should elapse before use of the triamcinolone oral inhaler to reduce the potential toxicity from the inhaled fluorocarbon propellants in the two aerosols. <br><br>

<strong>Note:</strong> For further information, please see manufacturer's literature.
240 inhalations unit (60mg): 498.00 MRP </p>
        </div><!-- collapsible -->
      </div><!-- collapsible-set -->


<a href="#" data-role="button" data-theme="a"> </a>
      <div data-role="collapsible-set" data-theme="b">
       <div data-role="collapsible"> <!-- collapsible -->
          <h3> SALMETEROL + FLUTICASONE  </h3>
          <p> 
Accuhaler/Cozyhaler/Evohaler/Rotahaler
These combined inhalation preparations of salmeterol xinafoate INN and fluticasone propionate BP are available as Accuhaler (dry powder inhalation), Cozyhaler (dry powder inhalation), Evohaler (aerosol inhalation) and Metered dose inhaler (MDI- aerosol inhalation), and Rotahaler (dry powder inhalation), Accuhaler, Cozyhaler & Rotahalar, all are DPI (dry powder inhalation) device and are used by oral inhalation only.
Evohaler is a MDI (metered dose inhalation) device and is used by aerosol inhalation only. Mode of action: Salmeterol xinafoate is a selective, long acting beta-2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone propionate is stated to exert a topical effect on the lungs without systemic effects at usual dose. <br><br>

<strong>Ind:</strong> Regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) is appropriate, including patients on effective maintenance doses of long acting beta agonists and inhaled corticosteroids, patients who are symptomatic on current inhaled corticosteroid therapy and patients on regular bronchodilator therapy who require inhaled corticosteroids. <br><br>

<strong>C/I:</strong> History of hypersensitivity to any of
the ingredients. <br><br>

<strong>Adverse effects:</strong> The type and severity of adverse reactions associated with each of the compounds may be expected. There is no incidence of additional adverse events following concurrent administration of the two compounds. Therefore, adverse events which have been associated with salmeterol or fluticasone propionate (steroid) are almost same as with the individual preparation.
(Please see above, under the preparations of salmeterol & for fluticasone, under any steroid preparation such as beclomethasone inhaler).  <br><br>


<strong>Warnings & Precautions:</strong> This combined preparation is not for relief of acute symptoms, for which a fast and short-acting bronchodilator (e.g salbutamol) is required. Patients should be advised to have their relief medication available at all times. Increasing use of short-acting bronchodilators to relieve asthma symptoms indicates deterioration of asthma control. Sudden and progressive deterioration in control of asthma is potentially life threatening and the patient should be reviewed by a physician. Consideration should be given to increasing corticosteroid therapy. Also, where the current dosage has failed to give adequate cotrol of reversible obstructive airway disease, the patient should be reviewed by a physician. Consideration should be given to additional corticosteroid therapies, and include administration of antibiotics if an infection is present. Treatment with this preparation should not be stopped abruptly. As with all inhaled medication containing corticosteroids, it should be administered with caution in patients with active or quiescent pulmonary tuberculosis. These drugs should be administered with caution in patients with thyrotoxicosis. Rare instances of glaucoma and increased intra-ocular pressure have been reported following administration of inhaled corticosteroids. Care should be taken when transferring patients to this combined therapy, particularly if there is any reason to suppose that adrenal function is impaired from previous systemic steroid therapy. <br><br>


<strong>Pregnancy & Lactation:</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. <br><br>


<strong>Dosage & admin:</strong> The combined inhaler preparations of salmeterol and fluticasone are available as Accuhaler (dry powder for inhalation), Cozyhaler (dry powder for inhalation), Evohaler (aerosol inhalation), Metered dose inhaler (MDI- aerosol inhalation) and Rotahaler (dry powder inhalation). Accuhaler, Cozyhaler and Rotahaler, all are DPI (dry powder inhalation) device and are used by oral inhalation only.
Evohaler is a MDI (metered dose inhalation) device and is used by aerosol inhalation only. Individual patients will experience a variable time of onset and degree of symptom relief. Generally, preparation containing fluticasone propionate inhalation has a relatively rapid onset of action for an inhaled corticosteroid. Improvement in asthma control following inhaled administration of fluticasone propionate can occur within 24 hours of beginning the treatment, although maximum benefit may not be achieved for 1 to 2 weeks or longer after starting the treatment.
Patients should be made aware that the inhaler must be used regularly for optimum benefit. Patients should be regularly reassessed by a physician, so that the strength of inhaler they are receiving remains optimal and is only changed on medical advice. The dose should be adjusted to the lowest dose at which effective control of symptoms is maintained. Patients should be given the strength of inhaler containing the appropriate fluticasone propionate dosage for the severity of their disease.
Recommended dosage regimens: See below under the individual preparation.   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> AXINAT-F Inhaler (MDI) Acme </h3>
          <p> Axinat-F Inhaler 125- metered dose inhaler
containing 25mcg of salmeterol xinafoate INN and 125mcg of fluticasone propionate BP (delivered from the inhaler) per actuation. Axinat-F Inhaler 250- metered dose inhaler containing 25mcg of salmeterol xinafoate INN and 250mcg of fluticasone propionate BP (delivered from the inhaler) per actuation.  <br><br>

<strong>Ind:</strong> See above under the text of salmeterol & fluticasone combined preparation. <br><br>

<strong>C/I; S/E; Warnings & precautions:</strong> See above under the text of salmeterol & fluticasone combined preparation. <br><br>

<strong>Dosage & admin:</strong> General consideration: See above under the text.
Recommended dosage regimens: Axinat-F inhaler is to be used by aerosol
inhalation only. <br>
Adults & adolescents over 12 years: 2 inhalations of Axinat-F containing fluticasone 125mcg in moderate to severe and 250mcg in severe asthma twice daily. <br>

<strong>Children 4-12 years:</strong> Axinat-F 125 and AxinatF 250 is not applicable in cases of children. Special patients groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment. <br><br>

<strong>Note:</strong> For further information, please consult manufacturer's literature.
Axinat-F 125 (120 doses unit) x l's: 575.00 MRP Axinat-F 250 (120 doses unit) x Ps: 750.00 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> BEXITROL-F Inhaler (MDI) Beximco  </h3>
          <p> Bexitrol-F Inhaler 25/50- metered dose inhaler
containing 25mcg of salmeterol xinafoate INN and 50mcg of fluticasone propionate BP (delivered from the inhaler) per actuation. Bexitrol-F Inhaler 25/125- metered dose inhaler containing 25mcg of salmeterol xinafoate INN and 125mcg of fluticasone propionate BP (delivered from the inhaler) per actuation. Bexitrol-F Inhaler 25/250- metered dose inhaler containing 25mcg of salmeterol xinafoate INN and 250mcg of fluticasone propionate BP (delivered from the inhaler) per actuation. <br><br>

<strong>Ind:</strong> See above under the text of salmeterol & fluticasone combined preparation. <br><br>

<strong>C/I; S/E; Warnings & precautions</strong>: See above under the text of salmeterol & fluticasone
combined preparation. <br><br>

<strong>Dosage & admin:</strong> General consideration: See above under the text.
Recommended dosage regimens: Bexitrol-F inhaler is to be used by aerosol inhalation only.
Adults & adolescents over 12 years: 2 inhalations of Bexitrol-F containing fluticasone 50mcg in mild to moderate, 125mcg in moderate to severe and 250mcg in severe asthma twice daily. <br>
<strong>Children 4-12 years:</strong> 2 inhalations of Bexitrol-F containing fluticasone 50mcg twice daily. The dose can be reduced to 2 inhalations once daily if control maintained. <br>
Special patients groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment. <br><br>

<strong>Note:</strong> For further information, please consult manufacturer's literature.
Bexitrol-F 25/50 (120 doses unit) x l's: 500.00 IP Bexitrol-F 25/125 (120 doses unit) x l's: 575.00 IP
Bexitrol-F 25/250 .(120 doses unit) x l's: 750.00 IP   </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3>  SERETIDE Accuhaler/Evohaler GlaxoSmithKline </h3>
          <p>  Seretide 100 Accuhaler (DPI)- moulded plastic device containing a foil strip with 60 blisters, each containing 50mcg of salmeterol xinafoate and 100mcg of fluticasone propionate.
Seretide 250 Accuhaler (DPI)- moulded plastic device containing a foil strip with 60 blisters, each containing 50mcg of salmeterol xinafoate and 250mcg of fluticasone propionate.
Seretide 500 Accuhaler (DPI)- moulded plastic device containing a foil strip with 60 blisters, each containing 50mcg of salmeterol xinafoate and 500mcg of fluticasone propionate.
Seretide 50 Evohaler (MDI)- CFC free metered dose inhaler containing 25mcg of salmeterol xinafoate and 50mcg of fluticasone propionate (delivered from the valve) per actuation. Seretide 125 Evohaler (MDI)- CFC free metered dose inhaler containing 25mcg of salmeterol xinafoate and 125mcg of fluticasone propionate (delivered from the valve) per actuation. Seretide 250 Evohaler (MDI)- CFC free metered dose inhaler containing 25mcg of salmeterol xinafoate and 250mcg of fluticasone propionate (delivered from the valve) per actuation. <br><br>

<strong>Ind:</strong> See above under the text of salmeterol & fluticasone combined preparation. <br><br>

<strong>C/I; S/E; Warnings & precautions:</strong> See above under the text of salmeterol & fluticasone combined preparation. <br><br>

<strong>Dosage & admin:</strong> General consideration: See above under the text.
Recommended dosage regimens of Seretide accuhaler:
Seretide accuhaler (dry powder inhalation) is for oral inhalation only.  <br>

<strong>Adults & adolescents over 12 years:</strong>
1 inhalation of Seretide accuhaler containing fluticasone 100mcg in mild to moderate, 250mcg in moderate to severe and 500mcg in severe asthma twice daily. <br>

<strong>Children 4-12 years:</strong> 1 inhalation of Seretide accuhaler containing fluticasone 100mcg twice daily. The dose can be reduced to 1 inhalation once daily if control maintained. Recommended dosage regimens of Seretide evohaler:
Seretide evohaler is to be used by aerosol inhalation only. <br>

<strong>Adults & adolescents over 12 years:</strong> 2 inhalations of Seretide evohaler containing fluticasone 50mcg in mild to moderate, 125mcg in moderate to severe and 250mcg in severe asthma twice daily. <br>

<strong>Children 4-12 years:</strong> 2 inhalations of Seretide evohaler containing fluticasone 50mcg twice daily. The dose can be reduced to 2 inhalations once daily if control maintained. <br>

<strong>Special patients groups:</strong> There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment.
Note: For further information, please consult manufacturer's literature.
Prices: <br>
Seretide 100 Accuhaler x 60 doses (inhalations) unit: 1400.00 MRP <br>
Seretide 250 Accuhaler x 60 doses (inhalations) unit: 1600.00 MRP <br>
Seretide 500 Accuhaler x 60 doses (inhalations) unit: 2000.00 MRP <br>
Seretide 50 Evohaler x 120 doses (inhalations) unit: 750.00 MRP <br>
Seretide 125 Evohaler x 120 doses (inhalations) unit: 900.00 MRP <br>
Seretide 250 Evohaler x 120 doses (inhalations) unit: 1100.00 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> SALFLU Inhaler (DPI) Acme </h3>
          <p>  Salflu 100 inhaler- Salmeterol xinafoate INN 50mcg & fluticasone propionate BP 100mcg. Salflu 250 inhaler- Salmeterol xinafoate INN 50mcg & fluticasone propionate BP 250mcg. Salflu 500 inhaler- Salmeterol xinafoate INN 50mcg & fluticasone propionate BP 500mcg. Salflu inhaler is a DPI (dry powder inhalation) system and administered by Rotahaler device through oral inhalation route.
Rotahaler, a dry powder inhalation (DPI) device. Ind: See above under the text of salmeterol & fluticasone combined preparation.
 <br><br>

C/I; S/E; Warnings & precautions: See above under the text of salmeterol & fluticasone combined preparation. <br><br>

Dosage & admin: <br>
General consideration: See above under the text. 
Recommended dosage regimens of Salflu inhaler: <br>
Salflu inhaler (dry powder inhalation) is for oral inhalation only. Rinsing the mouth after inhalation is advised. <br>
Adults & adolescents over 12 years:
1 inhalation of Salflu inhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe and 500mcg in severe asthma twice daily. <br>
Children 4-12 years: 1 inhalation of Salflu inhaler containing fluticasone 100mcg twice daily. The dose can be reduced to 1 inhalation once daily if control maintained. <br>
Special patients groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment. <br>

Note: For further information, please consult manufacturer's literature.
Salflu 100 x 30's pack: 142.50 MRP Salflu 250 x 30's pack: 270.00 MRP Salflu 500 x 30's pack: 450.00 MRP </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> TICAMET Cozycap (DPI) Square  </h3>
          <p>  Ticamet 100 cozycap (DPI)- each cozycap contains salmeterol zinafoate INN 50mcg & fluticasone propionate BP 100mcg: dry powder inhalation.
Ticamet 250 cozycap (DPI)- each cozycap contains salmeterol zinafoate INN 50mcg & fluticasone propionate BP 250mcg: dry powder inhalation.
'Cozycap' is a pre-metered single dose medication for inhalation, specially to be used with 'cozyhaler'.
Cozycap contains an admixture of micronised drug (less than 5m) with a carrier, lactose.
'Cozyhaler'- the dry powder inhalation (DPI) device, using cozycap, which is an effective and well accepted device for patients with asthma. Cozyhalers are commercially available from Square Pharmaceuticals Ltd. <br><br>

Ind: See above under the text of salmeterol & fluticasone combined preparation. <br><br>

C/I; S/E; Warnings & precautions: See above under the text of salmeterol & fluticasone combined preparation. <br><br>

Dosage & admin: General consideration: See above under the text.
Recommended dosage regimens of Ticmaet cozyhaler:
Ticmaet cozyhaler (dry powder inhalation) is for oral inhalation only. Rinsing the mouth after inhalation is asvised.
Adults & adolescents over 12 years:
1 inhalation of Ticamet cozyhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe asthma twice daily.
Children 4-12 years: 1 inhalation of Ticmaet cozyhaler containing fluticasone 100mcg twice daily. The dose can be reduced to 1 inhalation once daily if control maintained.
Special patients groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment. <br><br>

Note: For further information, please consult manufacturer's literature.
Ticamet 100 x 30's pack: 144.90 MRP Ticamet 250 x 30's pack: 275.10 MRP  </p>
        </div><!-- collapsible -->

        <div data-role="collapsible"> <!-- collapsible -->
          <h3> TICAMET Inhaler (MDI) Square  </h3>
          <p>  Ticamet 50 Inhaler (MDI)- each actuation or dose contains salmeterol xinafoate INN 25mcg and fluticasone propionate BP 50mcg: metered dose inhalation.
Ticamet 125 Inhaler (MDI)- each actuation or dose contains salmeterol xinafoate INN 25mcg and fluticasone propionate BP 125mcg: metered dose inhalation.
Ticamet 250 Inhaler (MDI)- each actuation or dose contains salmeterol xinafoate INN 25mcg and fluticasone propionate BP 250mcg: metered dose inhalation.  <br><br>

Ind: See above under the text of salmeterol & fluticasone combined preparation. <br><br>

C/I; S/E; Warnings & precautions: See above under the text of salmeterol & fluticasone combined preparation. <br><br>

Dosage & admin: General consideration: See above under the text.
Recommended dosage regimens:
Ticamet inhaler is to be used by aerosol inhalation only.
Adults & adolescents over 12 years: 2 inhalations of Ticmaet 125 (containing fluticasone 125mcg) in moderate to severe and Ticamet 250 (containing fluticasone 250mcg) in severe asthma twice daily. <br>

Special patients groups: There is no need to adjust the dose in elderly patients or in those with renal impairment. There are no data available for use of inhaler in patients with hepatic impairment. <br>

Children 4-12 years: Ticamet inhaler not available for this group of patients. Note: For further information, please consult manufacturer's literature. <br>
Ticamet 50 Inhaler (120 doses unit) x l's: 525.00 MRP <br>
Ticamet 125 Inhaler (120 doses unit) x l's: 575.00 MRP <br>
Ticamet 250 Inhaler (120 doses unit) x l's: 750.00 MRP  </p>
        </div><!-- collapsible -->     
      </div><!-- collapsible-set -->


    </div><!-- content --> 


   <div data-role="footer" data-position="fixed">
      <h4></h4>
   </div>
</div>  <!-- /page snippet -->
	
</body> 
</html> 
